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Dual-use of electronic (e-cigarettes) and tobacco cigarettes has increased in the past few years 
(Czoli et al.,  2015) without evidence of it being effective as a smoking cessation aid (Manzoli et 
al., 2015). Understanding quitting tobacco use while using e-cigarettes continues to be a public 
health priority. There are limited studies, especially from Canada, that examine smoking 
abstinence among young adult e-cigarette users and non-users. This study examined the 
relationship between e-cigarette use and smoking cessation over a six-month period. 
 
Methods 
Secondary analysis of longitudinal data obtained from a randomized controlled trial survey for 
Crush the Crave (CTC), a smartphone-based cessation intervention, was conducted with a 
sample of 851 Canadian young adult smokers. Persistent e-cigarette use (within the trial) was 
defined as using e-cigarettes at both baseline and 6-month follow-up. Use of e-cigarettes only at 
baseline or at follow-up was defined as transient use. Non-users did not use e-cigarettes at either 
baseline or follow-up. People who ever used nicotine-containing e-cigarettes were also compared 
for 30 and 7-day point prevalence abstinence at 6 months. Socio-demographic, psychological and 
quit support usage predictors were also examined. Using logistic regression, odds ratios were 
calculated for the rates of cessation achieved for all e-cigarette user categories before and after 




Dual users who continued to smoke at 6-month follow-up survey (persistent e-cigarette users) 
had a lower 30-day cessation rate than transient or non-users (13% vs 23% and 29%, 
respectively). This was validated by the odds ratio, non-users being three times more likely to 
quit than persistent users, even after adjusting for other predictors (OR=3.2, 95% CI [1.41-7.40], 
p<0.01). Smokers with high self-efficacy were about twice as likely to quit than people with low 
efficacy (OR=1.92, 95% CI [1.14–3.21], p<0.05), even after adjusting for presumed causes of 
cessation. The majority of persistent e-cigarette users perceived e-cigarettes as a quit aid 
(χ
2
=5.70, p<0.05) and had high self-efficacy to quit at follow-up (χ
2
=15.5, p<0.01). No 




Persistent use of e-cigarettes, across the course of study, was associated with a lower rate of 
smoking cessation while transient use of e-cigarettes and no use of e-cigarettes was associated 
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A. Tobacco use and control in Canada and Internationally 
 
Despite ongoing efforts to lower smoking rates, tobacco use still remains a highly prevalent 
cause of death in Canada (Czoli et al., 2015; Government of Canada, 2017). Although overall 
rates of smoking cessation among ever users have changed from 52% in 2001 to 63% now, 4.6 
million people still use tobacco, and amongst them, young adults (19-29 years) smoking at 20 
percent prevalence still remains an important public health challenge (Government of Canada, 
2014; Government of Canada, 2017). The detrimental effects of tobacco use have been widely 
seen, in the form of diseases such as cancers, respiratory illness and heart diseases (US 
Department of Health and Human Services, 2014), proportionately causing a huge national 
economic burden. Over 3% of Canadian and the USA annual gross domestic products (GDP) 
represent the total expenditure towards smoking-attributable diseases, which is just next to 
Europe, where the costs reach up to 3.6% of the total GDP (Goodchild, Nargis, & Tursan, 2017). 
The addictive power of nicotine poses barriers to smoking cessation and thus tobacco 
dependence has been considered a disorder that could be treated by a number of cessation 
support resources (Health Canada, 2012a). Currently, support is provided for people intending to 
quit in the form of pharmacotherapy, motivational therapies or health professional's advice 
(Saitta, Ferro, & Polosa, 2014). However, too often these interventions eventually lead to relapse 
and are, therefore, considered inefficacious in real-life settings (Casella, Caponnetto, & Polosa, 
2010). Thus, the search for more effective alternatives for cessation and harm reduction from 
cigarette smoking remains necessary.  
 
 E-cigarettes have been claimed to be an effective alternative but are a source of 
considerable debate. Two knowledge synthesis projects were conducted in order to consolidate 
the research on e-cigarettes. The Clearing the Air Project, University of Victoria, and the Ontario 
Tobacco Research Unit (OTRU) both studied e-cigarettes as cessation aids, transitions in tobacco 
use, health effects, second-hand vapor and patterns of use (McDonald, O‘Leary, Stockwell, & 
Reist, 2016; OTRU, 2016). Both projects conclude that further research is needed in areas of 




youth while acknowledging their potential use in harm reduction and cessation programs. Dual-
use has shown to reduce the number of cigarettes people use daily (Manzoli et al., 2016). 
However, additional health problems have also been attributed to the "dual-use" of tobacco 
products (Manzoli et al., 2015). Evidence suggests that dual-use is not associated with reducing 
smoking cessation rates (Zhuang, Cummins, Sun, & Zhu, 2016). The use of e-cigarettes (EC) 
may make people feel better. However, the research shows the opposite effect (Khoury et al., 
2016; Stanbrook, 2016). Thus, complete cessation may not be considered by smokers and 
maintenance of cigarette smoking occurs.  
 
 Since 2001, Canada has taken a number of steps towards tobacco control through the 
Federal Tobacco Control Strategy (FTCS). It works towards the goals of prevention, protection, 
cessation and product regulation. The Tobacco Act, which came into effect in 1997, is the key 
measure of the FTCS which governs the sales, manufacturing, labeling, and promotion of 
tobacco products (Government of Canada, 2017). The Tobacco Control Directorate of the 
Healthy Environments and Consumer Safety Branch oversees the administration of the Act 
whereas the Regulatory Operations and Regions Branch manages the investigation issues 
(Government of Canada, 2017). In 2005, in response to the global tobacco epidemic, Canada 
collaborated with179 other jurisdictions to form the World Health Organization Framework 
Convention on Tobacco Control (Government of Canada, 2017). Health Canada actively 
monitors tobacco manufacturers, importers, and retailers' compliance with the Tobacco Act. 
Health Canada is also responsible for enforcement activities, such as health warnings and 
labelling, based on the Tobacco Products Labelling Regulations (Cigarettes and Little Cigars) 
(2011) (Government of Canada, 2017). Canada has also provided the public with cessation 
support services such as the Quit4Life program and provincial and territorial quitlines 
(Government of Canada, 2015). Additionally, Health Canada supports a clinical model, known 
as Ottawa Model for Smoking Cessation (OMSC) in hospital settings. It works on the principles 
of identification, documentation, treatment (in the form of pharmacotherapy and counselling), 
follow-ups and referrals. OMSC shows a promising role in increasing cessation rates and has 
been adopted by 144 healthcare organizations between 2006 and 2012 (Ottawa Model, 2012). 





 Apart from Canada, more than 70 countries have national or federal laws regulating the 
sale, advertisement, promotion, sponsorship, taxation, use and classification of e-cigarettes 
(Institute for Global Tobacco Control, 2016). Of  71 countries, 56 have regulations that prohibit 
or restrict the sale of e-cigarettes; 18 countries regulate e-cigarettes as medicinal products; 26 
countries regulate e-cigarettes as tobacco products; and, four countries regulate nicotine-
containing e-cigarettes as poisons (Institute for Global Tobacco Control, 2016). Since 2016, the 
UK has introduced a regulation which licenses e-cigarettes as a medicine (Olov & Bridgman, 
2014). However, Canada shows distinct features in marketing nicotine-free products and nicotine 
containing e-cigarette brands, at least when compared to the United States due to the latest policy 
framework (discussed further below) (Hammond et al., 2015).  
B. Rise of electronic cigarettes 
 
Over the past few years, the electronic cigarette market  has seen  an exponential growth. 
According to Euromonitor International, global e-cigarette sales reached $6 billion USD in 2014, 
outweighing the market value of nicotine replacement therapy (NRT) products (Pepper & 
Brewer, 2013). Furthermore, the e-cigarette market is expected to exceed US$23 billion by 2019 
(MacGuill et al., 2014; Modi, Schmid, & Miller, 2013; Pepper & Brewer, 2013; Saitta et al., 
2014). Analysts estimate that the e-cigarette market will grow larger than of the market for 
conventional cigarettes by 2023 (Herzog & Gerberi, 2013). Therefore, the government would 
benefit from evidence that would support their policy analyses as to whether Canadian policies 
should either promote, restrict or prohibit electronic cigarette markets. 
 E-cigarettes are a major cause of concern due to their high rates of use. Almost 20% of 
young adults, aged 20-24, have ever used or are currently using them (Czoli et al., 2015).  There 
has been an ongoing debate concerning e-cigarette use and the growing number of dual users in 
Canada. Regardless of the absence of compelling evidence on their effectiveness (McRobbie, 
Bullen, Hartmann-Boyce, & Hajek, 2014) and absence of any examination of their long-term 
health effects (Grana, Benowitz, & Glantz, 2014), these devices are being sold in the markets as 
potential cessation aids and/or as safer alternatives to conventional tobacco (Adkison et al., 2013; 
Benowitz & Goniewicz, 2013; Centre for Disease Control, 2014; Czoli, Hammond, & White, 




smoking cessation is the topic of ongoing debate (Cobb, Byron, Abrams, & Shields, 2010) which 
needs further study.  
 According to 2013 Canadian Tobacco, Alcohol and Drugs Survey (CTADS) data, the 
majority (78%) of e-cigarette users also reported smoking tobacco cigarettes (Czoli et al., 2015). 
People, who otherwise might have quit, generally give preference to e-cigarette smoking 
(including in smoke-free places) leading to sustained smoking behavior (Grana et al., 2014). 
With age, the proportion of people using e-cigarettes has been found to increase (Czoli et al., 
2015). Despite the high prevalence of dual-use in Canada, evidence regarding dual-use behaviors 
and their impact on cessation is very scarce. Some population surveys have been successful in 
examining e-cigarette use among Canadians (Czoli, Hammond, Reid, Cole, & Leatherdale, 2015; 
Hamilton, Ferrence, Boak, Schwartz, Mann, O‘Connor & Adlaf, 2015; Hammond et al., 2015; 
Shiplo, Czoli, & Hammond, 2015). However, these studies did not examine the rates of cessation 
among dual users as a distinct category. For example, the International Tobacco Control Four-
Country Survey 2010-2011 results from four different nations stated the reasons for e-cigarette 
use but did not consider dual-use as a separate group (Adkison et al., 2013). The extent to which 
"dual-use" of e-cigarettes leads to smoking cessation or support future smoking remains unclear.  
C. Policy Context 
 
Within Canada, several provinces have placed restrictions on e-cigarette use, while 
municipalities, local school boards and boards of health have enacted their own bylaws and 
regulations to address this issue. In effect of the recommendations provided by the House of 
Commons Standing Committee on Health, Environment, and Social Affairs (HESA) to amend 
the previous legislation or develop a new legislation altogether, the Bill S-5 was introduced in 
November 2016, which amends the Tobacco Act and Non-Smoker's Health Act, by prohibiting 
the sale of e-cigarettes or ENDS to minors (Norris, 2017). While Big Tobacco companies are 
promoting dual-use instead of harm reduction, the bill prohibits the promotion and advertising of 
flavored devices (Norris, 2017). The Act also mandates manufacturers to provide detailed 
information about the vaping products to the Minister of Health before selling them (Norris, 
2017). Compared to the previous legislation, it imposes higher penalties for tobacco-related 
offences. Further, e-cigarettes are regulated by the Food and Drugs Act (FDA) and the Food and 




specified by Health Canada, which is 4 mg per dosage unit (Health Canada, 2017). The new 
legislation also complements provincial regulations established across eight provinces (excluding 
Alberta and Saskatchewan) (Government of Canada, 2016b; Norris, 2017). 
 
 The purpose of this thesis was to use an available RCT data source which enrolled young 
adults through an online survey conducted across Canada to check for the effectiveness of a 
smartphone cessation application in smoking cessation (Baskerville et al., 2015). More 
specifically, this thesis focuses on understanding the differences in the rates of cessation 
achieved between dual users (consuming both e-cigarettes and conventional tobacco cigarettes) 
and non-users of e-cigarettes. Second, it was further designed to understand the relationship of 
cessation with e-cigarette use when other proximal and distal factors such as self-efficacy, the 
level of nicotine addiction, social norms, quit attempts, use of other cessation resources and other 
socio-demographics are taken into consideration. Bivariate and multivariable regression models 
were developed to examine the rates of smoking cessation among independent variable measures 
of e-cigarette use, nicotine containing e-cigarette use separately, and then subsequently including 
socio-demographic, psychological and quit supports usage characteristics. 
 
 The thesis is organized by first providing a brief review of what is currently known about 
e-cigarettes and dual-use and their relation to smoking cessation. Following that, the literature 
pertaining to other factors potentially causally associated with cessation is reviewed briefly. 
Based on the review of the literature, research questions are then outlined. Further, the methods 
used to answer the research questions will be explained. Results follow and the discussion 
















E-cigarettes (ECs) are rising in popularity among smokers and may reinforce the concept of 
smoking (Chapman & Wakefield, 2013). However, the evidence that e-cigarettes could harm or 
help smokers quit smoking is not very well-established (Kandel et al, 2015). Despite the ongoing 
debate on e-cigarettes' effectiveness for cessation, not many studies provide compelling evidence 
(Malas et al., 2016; Manzoli et al., 2016). Based on 12 primarily moderate-to-weak quality 
reviews, there is a widespread view that ECs may be less harmful to smokers, but evidence in 
support of ECs as a smoking cessation aid is uncertain. The literature covered by these reviews is 
limited and of low quality, and authors caution about insufficient research on the efficacy of ECs 
in cessation (McRobbie et al., 2014). Evaluating potential long-term health effects of EC use is 
an important research priority (Andrade & Hastings, 2013; Environmental, Committee, & 
Committee, 2014). 
 
A. E-cigarettes and dual-use 
 
1.  E-cigarettes 
 
Electronic nicotine delivery systems (ENDS), popularly known as electronic cigarettes or e-
cigarettes (ECs) are battery-operated products designed to deliver nicotine, flavor (for example; 
classic tobacco and menthol) or other chemicals such as propylene glycol and glycerine water, 
that are attached to a glowing light-emitting diode tip. These products work through an 
inhalation-activated system that heats a solution to create an inhalable aerosol, often known as 
vapor (McNeill et al., 2015; Pepper & Brewer, 2013). Alternatively, nicotine-free solutions are 
also available, known as ‗e-liquid‘ or ‗e-juice‘ (McNeill et al., 2015). E-cigarettes come in four 
different forms: mini or ‗cig-a-like‘ that look like conventional cigarettes and can be disposed of 
or reused with disposable solution cartridges; mid-size or ‗vape pen‘ which are recommended for 
heavy smokers; 'tank-style' e-cigarettes that are refillable with solution and do not resemble 
conventional cigarettes; and ‗variable power EC‘ systems of variable appearance with user 





 E-cigarettes were first developed by a Chinese pharmacist, Hon Lik, in 2003 and their use 
rose globally after 2004. The disposable forms of EC first appeared in the Canadian market in 
2007 (Torjesen, 2013) and following that, Health Canada in 2009 issued an advisory against the 
nicotine-containing products due to a lack of evidence to support the safety of the devices 
(Health Canada, 2009). ECs have been heralded by manufacturers and in advertising as a 
completely harmless alternative to smoking (Bass, 2016). The popularity of ECs as a smoking 
cessation aid rose during the periods when globally, only individual manufacturers of these new 
products were available (Hajek, Etter, Benowitz, Eissenberg, & McRobbie, 2014; McRobbie et 
al., 2014). Later the tobacco industry overtook independent stakeholders of ECs and developed 
their own patents (Kamerow, 2013). As compared to the US, the Canadian market excels in 
providing distinct varieties of nicotine-free products and many e-cigarette brands (Hammond et 
al., 2015) such as 'vapor' and 'South Beach Smoke'. Currently, e-cigarettes are being sold in 
Canada as a potential smoking cessation aid or as an alternative to smoking in restricted places 
such as restaurants, airports, public parks, patios etc. (Benowitz & Goniewicz, 2013; 
Henningfield & Zaatari, 2010; Volesky et al., 2016). Studies mention that e-cigarettes reinforce 
the attraction of cigarette smoking all over again due to various factors. Some of these 
influencers, in relation to ECs, include their enhanced appeal, exhalable vapor, frequent public 
display of the hand-to-mouth gestures, and risk associated nature (Chapman & Wakefield, 2013). 
These very cigarette-like factors permit users to mimic smokers, which is more than other 
cessation aids (Chapman & Wakefield, 2013). 
  
 In 2015, HESA released a health report, Vaping: Towards a Regulatory Framework for 
E-cigarettes that recommended the government to either amend the previous legislations or form 
a new legislation as the committee identified a lack of clear evidence around the health effects of 
ECs (Lobb, 2015). In effect of that, Bill S-5 was introduced in November 2016, to implement a 
policy framework for vaping products. The Bill proposes to amend the Tobacco Act and Non-
Smoker's Health Act, by prohibiting the sale of e-cigarettes or ENDS to minors and prohibiting 
the promotion and advertising of flavored devices (Norris, 2017). In addition to that, the bill 
mandates manufacturers to provide detailed information about the vaping products to the 
Minister of Health before selling them (Norris, 2017). Compared to previous legislation, it 




FDA and the Food and Drug Regulations, when the nicotine content is found to be more than the 
limit specified by Health Canada, which is 4 mg per dosage unit (Health Canada, 2017). 
 
2. Dual-use of E-cigarettes and tobacco cigarettes 
 
The Centers for Disease Control and Prevention (CDC) defines "dual-use" as the use of an 
additional tobacco product by someone intending to reduce cigarette consumption and harm to 
health (CDC, 2017). Data from the 2013 CTADS describe the prevalence of dual-use in the 
Canadian context. Dual-use appears to be common, given that the majority (78%) of e-cigarettes 
users also reported smoking tobacco cigarettes concurrently (Czoli et al, 2015). The proportion 
of dual users was lowest among youth aged 15-19 years (47%). The proportion of dual users 
generally increased with age: 79% of young adults aged 20-24, 78% of adults aged 25-44, and 
89% of adults aged 45+ years were found to be using both the forms (Czoli et al, 2015). In 
addition to CTADS, the data from other population survey studies also highlight the 
simultaneous use of conventional cigarettes as being the most common behavior among young 
EC users (Czoli et al., 2015; Grana et al., 2014; Hamilton et al., 2015; Shiplo et al., 2015). 
However, these population studies did not examine smoking cessation behaviors among dual 
users as a distinct subpopulation.  
 
 A recent study suggests that ECs are not a substitute for cigarettes but a complement to 
smoking (Khoury et al., 2016; Stanbrook, 2016). The study found that the odds of EC use was 
12-times higher for youth who smoked cigarettes. An International Tobacco Control Four-
Country Survey from 2010-2011 reported rates of and reasons for use of e-cigarettes among 
former and current smokers, but their pooled results from across four countries' study population 
are not representative of Canada (Canada, the US, the United Kingdom, and Australia) (Adkison 
et al., 2013). Therefore, despite the high prevalence of dual-use in Canada and some potential 
evidence of greater EC use among tobacco smokers, evidence regarding dual-use behaviors and 
effectiveness of dual-use in smoking cessation is very scarce. 
  
 There are factors significantly associated with dual-use: education, the number of 
cigarettes smoked per day and some EC-associated factors such as product choice, EC 
consumption, reasons for usage and health risk perception (Farsalinos, Romagna, & Voudris, 




because of their potential to yield both positive (smoking reduction or cessation) and negative 
(delay of cessation) impacts (Benowitz & Goniewicz, 2013; Rass, Pacek, Johnson, & Johnson, 
2015). One study found a positive association between rising dual-use and lower smoking 
cessation intentions that could further have implications for public health practice and cessation 
clinic services (Huang et al., 2016). Concerns have also been raised about dual-use exposing 
people to greater health risks, in the form of elevated nicotine levels in the body. A study 
established that both tobacco cigarette-only users and the dual users had similar levels of 
tobacco-specific N-nitrosamines (TSNAs), and volatile organic compounds (VOCs) signifying 
that there was no reduction in the levels of carcinogens and toxins among dual users (Shahab et 
al., 2017). It has been found that smokers like to maintain stable blood nicotine levels and hence 
takes nicotine from an alternative source, such as ECs, that might have the potential to reduce 
nicotine intake from cigarettes, followed by a reduction in smoke and toxin intake (Rusell, 
1990). Another study found an effective action of dual-use while assessing the biochemical 
changes, supported by the evidence of a significant decrease in cotinine and exhaled carbon 
monoxide levels (McRobbie et al., 2014). Apart from that, a prospective cohort study also found 
that e-cigarette use might benefit tobacco quitters to remain abstinent from smoking (Manzoli et 
al., 2016). Therefore, the research done so far suggests an ambivalent relationship between dual-
use and smoking cessation. 
 
3. Prevalence of dual-use in young adults 
 
A smoking rate of 20% among young adults remains a public health challenge (Government of 
Canada, 2014). The proportion of dual users, who are both current cigarette users and e-cigarette 
users has been found to be 79% for young adults aged 20-24, higher than for youth aged 15-19 
(47%), and adults aged 25-44 (78%) and lower than adults aged 45 and above (89%) (Czoli et 
al., 2015). Young adulthood deserve special attention because it is a period of risk as well as 
opportunity (Oesterle, 2013). In Canada, the young adult period begins for most with high school 
graduation around age 19 and lasts into the late 20s and early 30s. The transition of age from 19 
to 29 years has been suggested, by many researchers, to have potential implications for health, 
well-being and quality of life in later adulthood (Arnett, 2000; George, 1993; Hogan & Astone, 
1986; Macmillan & Eliason, 2003; Shanahan, 2000). People in transition age, generally continue 




& Caspi, 1988). Alternatively, they could change from negative to more positive attitudes. There 
is also a chance of interrupting and disrupting a healthy life trajectory (Feinstein & Bynner, 
2004; Schulenberg & Maggs, 2002). The success of early life preventive interventions may be 
crucial for later health and well-being, although very little is known about how to intervene 
during the transition to adulthood (Oesterle, 2013).  
 As an at-risk group, young adults might be exposed to various other addictions. A recent 
study found that dual users have a higher prevalence for other tobacco products as well, such as 
snus, chew or hookah (Cooper, Case, Loukas, Creamer, & Perry, 2011). The California Tobacco 
Control Program has rated the importance of adults as important role models in a youth's lives 
(Zhang, Cowling & Tang, 2010). Furthermore, adults are policy makers that determine 
community-wide exposure to second-hand smoke (SHS), tobacco industry promotions and the 
enforcement of laws (Zhang et al., 2010). As almost 79% of the young adult smokers in Canada 
are dual users, they likely need special attention and care, to prevent further increase. 
4. E-cigarettes and Public Health 
 
Public health policy makers need a clear understanding of both the positive and negative aspects 
of e-cigarettes so that interventions they apply can promote population health. Effective 
legislation and policies get impeded by the lack of empirical evidence to guide decision making. 
The potential positive effect of ECs is to decrease tobacco use and ultimately reduce the harm 
caused by tobacco chemicals. Few Cochrane reviews further assessed whether nicotine-
containing ECs help smokers to stop smoking in the long run (more than six months) as 
compared to placebos (McNeill et al., 2015; McRobbie et al., 2014; Rahman, Hann, Wilson, 
Mnatzaganian, & Worrall-Carter, 2015). According to a 2015 Public Health England report, 
young adults' smoking rates have dropped, while the use of e-cigarettes has risen sharply among 
those trying to quit (35%). The report also predicts that by 2025, nicotine-containing ECs will 
make a significant impact in reducing the tobacco epidemic (Public Health England, 2015). 
 Considering the negative aspect, the public health is concerned about the increased risk of 
smoking initiation in e-cigarette users and nonsmokers who might later transition to dual-use or 
only cigarette use (Primack, Soneji, Stoolmiller, Fine, & Sargent, 2015). Canada has achieved 




nationally recognized reason for the continued decrease in the smoking prevalence (Health 
Canada, 1999; U.S. Department of Health and Human Services, 2012). Nevertheless, the factors 
such as an increased social acceptability of e-cigarette, easy accessibility, the belief that ECs are 
safer than tobacco cigarettes, and a rising EC use could potentially lead to social ―normalization‖ 
of smoking behaviours (Fairchild, Bayer, & Colgrove, 2014; Peters, Meshack, Lin, Hill, 2013). 
The association of ECs and normalization has been supported by a cross-sectional study that 
recognizes people's psychosocial environment, social acceptability of e-cigarettes (including 
friends' use and attitudes toward the use of e-cigarettes), to be strongly associated with cigarette 
smoking among never cigarette smokers (Barrington-Trimis et al., 2015). Additionally, EC's 
design mimicking conventional cigarettes might contribute to habitual smoking. An 
economically-oriented perspective still needs to be explored as to whether e-cigarettes need to be 
considered as a true substitute for cigarette use or as a complementary product (Doyle, Ronayne, 
& Sgroi, 2015). The extent to which e-cigarettes are substitutes or complements will have 
significant implications for the design and execution of public health policy. 
  Many  researchers have explored the claims about the increased likelihood of tobacco 
smoking due to e-cigarette use (Bam et al., 2014; Dutra & Glantz, 2014). A recent causal 
hypothesis proposed that EC may act as a "catalyst" (Schneider & Diehl, 2015), supporting 
Kandel's hypothesis. E-cigarettes have been consolidated by some to be a mediator to nicotine 
addiction and subsequent cigarette use, either through a pharmacologic pathway, or one 
involving social renormalization (or both). This may apply to adolescents or young adults who 
may otherwise never have tried cigarettes (Barrington-Trimis et al., 2016; Bell & Keane, 2014; 
Kandel & Kandel, 2015). A cross-sectional study also showed that nonsmoking Canadian youth 
who use e-cigarettes have about twice the susceptibility to cigarette smoking when compared 
with youth who do not use ECs (Azagba, Baskerville, & Foley, 2017). However, no causal 
relations could be inferred from these studies. All of these debatable points raise important 
public health issues that need to be addressed.  
 The vulnerability of adolescent's developing brain to the negative effects of the nicotine 
neurotoxin and nicotine dependence is also an issue of concern (McRobbie et al., 2014; Walley 
& Jenssen, 2015). Findings from a recent study recognize that nearly half of the physicians are 




tobacco and about one-fourth of them did not agree with the statement that ―E-cigarette could be 
a gateway to other tobacco use‖ (Pepper, McRee, & Gilkey, 2014). EC screening is yet not a part 
of routine medical practice. The longitudinal evidence predicts that early emerging dependence 
symptoms in adolescence lead to a greater predisposition for continued smoking behavior in 
young adulthood (Bunnell et al., 2015). E-cigarettes might also increase the likelihood of relapse 
among former smokers, although no empirical evidence is currently available (Rass et al., 2015). 
Having a better understanding of the relationship between dual-use, i.e. e-cigarette use among 
smokers, and smoking cessation behaviours among adolescents and young adults can help 
inform FDA on e-cigarette's harmful effects on health and correct misperceptions about their role 
in smoking cessation and nicotine addiction, hence providing users with adequate cessation 
support services. 
5. Harm reduction in Canada 
Harm reduction is a public health strategy used to reduce the health risks associated with using 
nicotine (THRA, 2016). However, among adults, nicotine itself does not cause the harm (Olov & 
Bridgman, 2014). Harm reduction focuses on reducing or eliminating the use of combustible 
forms of tobacco by switching to other nicotine products, decreasing the amount of smoking, 
inducing temporary abstinence, while using alternative non-tobacco nicotine containing products 
(such as pharmaceutical NRTs or e-cigarettes), or switching to other smokeless products (THRA, 
2016). Thus, harm reduction policies could help in reducing smoking rates which could result in 
a lower total population risk when compared with pursuing abstinence-only policies (NICE, 
2013). It is widely acknowledged that an ideal pathway to tobacco harm reduction is smoking 
cessation. However, majority of the smoking cessation methods have been found to be 
unsuccessful, when used as directed (Nitzkin, 2014). Moreover, the majority of smokers are 
unwilling to quit completely (Rodu & Godshall, 2006). Harm reduction is likely of substantial 
benefit to these unwilling smokers and public health (Nitzkin, 2014; Olov & Bridgman, 2014). 
 Despite the fact that smoking prevalence in Canada has significantly decreased during the 
last 40 years, the magnitude of tobacco-related diseases indicates that new strategies to reduce 
smoking prevalence are greatly in need. The e-cigarette has the capability to be accepted as a 




ability to deliver nicotine, they hold another "advantage" of being a close resemblance to 
conventional tobacco cigarette smoking (Franck et al., 2016). This additional "benefit" can be 
helpful in undoing the effects of psychological addiction (Anthopoulou, 2016).  It has been 
predicted the use of e-cigarettes to substantially reduce tobacco-related illness resulting in an 
estimated 4.8 million saved lives in the next 20 years in the USA (Nitzkin, 2014). Thus, 
considering the potential of e-cigarettes as smoking cessation aids, the harmful effects of tobacco 
smoking and the need for new smoking strategies, it becomes imperative for the government to 
ascertain whether e-cigarettes are effective and safe for health (Anthopoulou, 2016).  
 In 2015, the report released by Public Health England suggests that e-cigarettes are 95% 
less harmful than smoking (McNeill et al., 2015). In addition to reducing harm, they focussed on 
EC use in leading a long-term goal of stopping smoking completely (McNeill et al., 2015). The 
report also promotes the use of e-cigarettes, NRTs, and other non-tobacco nicotine products in 
the best interests of public health. In Canada, the current electronic cigarette regulatory 
framework has been developed on weak grounds with no strong evidence on its long-term 
effectiveness. ECs are increasing in popularity, and there is a need for new tobacco harm 
reduction strategies and generation of integrated regulatory policies. E-cigarettes are widely 
used and the preliminary findings on safety and efficacy, in combination with the need for new 
tobacco harm reduction strategies, suggest that the investigation of e-cigarettes' potential as a 
smoking cessation aid is important (Anthopoulou, 2016). 
B. Factors associated with successful cessation of tobacco use 
1. Self-efficacy 
 
The performance of a behavior that comprises of feelings, thoughts, and actions, are influenced 
by the perception of self-efficacy or simply "self-efficacy" (Bandura, 1986; Gandoy-Crego, 
Clemente, Gomez-Cantorna, Gonzalez-Rodriguez, & Reig-Botella, 2016). According to 
Bandura, self-efficacy is a personal assessment of one's ability to engage in a specific behavior in 
order to produce a favorable outcome (Bandura, 1978, 1997, 2004). It has been well established 
that high self-efficacy individuals succeed often in achieving intended outcomes, better than 
individuals with low self-efficacy (Mitchell, Hopper, Daniels, George-Falvy, & James, 1994). 




(Redmond, 2016). For example in a smoking cessation program, people failing to quit 
undermines other participants' self-efficacy weakening their own chances of success (Redmond, 
2016). The perception of self-efficacy facilitates cognition concerning one‘s own abilities, with 
thoughts acting as motivators of action. Finally, with regard to action, people who feel 
efficacious choose more challenging tasks, set higher goals, and persist more in their goals 
(Redmond, 2016). Social Cognitive Theory (SCT) emphasizes on the interaction of cognitive, 
behavioral, personal, and environmental factors to determine motivation and behavior (Crothers, 
Hughes, & Morine, 2008), as embodied in the Triadic Reciprocal Determinism model (Wood & 
Bandura, 1989). Self-efficacy, one of the processes under SCT, has been found to have an effect 
on motivation and goal attainment (Redmond, 2016). Apart from being related to quitting, self-
efficacy for cessation and abstinence continuation has been linked to relapse behavior also 
(Shiffman et al., 2000). Due to the high influence of self-efficacy in various smoking cessation 
and relapse models, most cognitive-behavioural smoking cessation supports aim for increasing 
participant's self-efficacy (Model, 1999). 
 
 There are situations that lead people to smoke such as; when out with friends, while 
getting up in the morning, under situations of stress and anxiety, while drinking coffee or while 
talking, when in need of energy boost, when in anger, when in a company of a smoker (Etter, 
Bergman, Humair, & Perneger, 2000). Previous surveys have evaluated "how tempted" smokers 
were to smoke in each situation. The questions asked in the survey used the five-point scale, 
known as Smoking Abstinence Self-efficacy Questionnaire (SASEQ) which shows a high 
predictive validity (Bandura, 1997; Spek et al., 2013; Williams & Rhodes, 2016). 
 
 The likeliness of EC use as a smoking cessation aid depends on self-efficacy, smoking 
cues and people's beliefs about EC use as a smoking cessation aid (Sherratt, Newson, Marcus, 
Field, & Robinson, 2016). The concept of self-efficacy is an important psychological construct 
which is specifically relevant to smoking cessation as evaluated in previous studies. Due to this 
relevance, it becomes a unique aspect to be measured while conducting surveys. Previous 
studies, for instance, showed that smokers with high confidence in their ability to quit smoking 
are often more successful in cessation (Baldwin et al., 2006; Chouinard & Robichaud-Ekstrand, 
2007). In addition, the studies on smoking cue reactivity and public service announcements, also 




& Shiffman, 2013; Lee, Cappella, Lerman, & Strasser, 2013). It has been found that exposure to 
certain smoking cues such as EC's advertisements might increase self-efficacy to quit smoking or 
continue abstaining, or on the contrary produce cravings for a tobacco cigarette (Maloney & 
Cappella, 2016). Further, a paper determined that the biggest reason for EC use among dual users 
in addiction treatment populations was its apparent use as a tool for cessation (Gubner, Le, 
Tajima, Andrews, & Passalacqua, 2015). However, this paper did not assess the level of 
addiction and self-efficacy of the people at the treatment center (Gubner et al., 2015). A recent 
study concluded that vapers were significantly more motivated to abstain from cigarettes and 
quit smoking than dual and cigarette-only users (Rüther et al., 2015). Hence, it can be seen that 
very limited studies provide evidence on the attitudes of dual, EC-only and non-EC users. On 
these grounds, the present work investigated the significant relationships between self-efficacy 
and smoking cessation. 
2. Social norms, beliefs, and attitudes 
 
Various studies have contributed evidence on societal norms, people's beliefs and attitudes 
regarding EC, dual and tobacco use. EC-only users were found to be more positively influenced 
by their social environment than dual users and non-EC users (Rüther et al., 2015). More friends, 
family, and colleagues preferred the use of EC rather than cigarettes (Rüther et al., 2015). A 
recent qualitative study analyzed the perceptions and beliefs of college students about smoking 
cessation in relation to e-cigarettes using verbatim transcripts and thematic analysis (Camenga et 
al., 2015). All the participants, regardless of age and smoking status, were aware that e-
cigarettes could be used for smoking cessation. However, overall, participants did not regard EC 
to be a cessation promoter (Camenga et al., 2015). Maintenance of smoking actions, "healthier" 
alternative to cigarettes, and parental approval were described as a positive attribute while 
persistence of cravings and maintenance of addiction were regarded as negative attributes of 
EC's role in smoking cessation. Some college students expressed distrust of marketing of e-
cigarettes for smoking cessation (Camenga et al., 2015). Future quantitative research is needed to 
determine the role of e-cigarettes for smoking cessation in this population. A study compared the 
strength of the relationship between the social norms, attitudes, and smoking behavioral 
outcomes (Zhang et al., 2010). The study included perceptions on second-hand smoke (SHS); on 




The study also included countering pro-tobacco influences (CPTI) norms such as bans in sports 
advertisement, ban on promotion item etc.. The results demonstrated a dose–response 
relationship with quit attempts (Zhang et al., 2010). The smokers who showed high values on 
both these constructs of SHS and CPTI were almost 70% more likely to make a quit attempt. 
Hence, it concluded that smokers with more positive attitudes towards CPTI and SHS reported 
more quit attempts and intentions (Zhang et al., 2010).  
 A qualitative study conducted among young straight-to-work young adults demonstrated 
the influence of family, friends, and society on e-cigarette use. Families encouraged e-cigarette 
smoking through positive comments and some parents preferred to offer e-cigarette to their 
young adult child in order to stop smoking (Cheney, Gowin, & Wann, 2016; Pokhrel, Herzog, 
Muranaka, Regmi, & Fagan, 2015). Friends also played a supportive role in young adult e-
cigarette use by providing positive reinforcement, sharing and gifting them. Moreover, these 
young adults felt that they were viewed positively by others when they were using e-cigarettes 
(Cheney et al., 2016). Smokers commonly report smoking cigarettes as a means of coping with 
stress (Pokhrel et al., 2015). Dual users might prefer cigarettes over e-cigarettes to relieve stress 
due to the probable reason of cigarettes‘ better nicotine delivery efficiency (Pokhrel et al., 2015). 
Although the evidence does not hold much support. This qualitative study indicated that dual-use 
is influenced by certain activities such as during strong craving or need for stimulation (e.g., in 
response to stress) (Pokhrel et al., 2015). EC use was found to be more conducive to physical 
activity. Moreover, co-workers too were tolerant of other people's EC use (Pokhrel et al., 2015).   
3. Level of addiction 
 
The level of nicotine addiction or dependence holds a central role in tobacco use. Some strong 
measures have been used to predict the validity of this measurement strategy. One of them was 
developed by Fagerström and his colleagues. His initial attempt developing the Fagerström 
Tolerance Questionnaire was later converted into the Fagerström Test for Nicotine Dependence 
(FTND) (Heatherton, Kozlowski, Frecker, & Fagerström, 1991). Later research concluded that 
time to first cigarette (TTFC) and cigarettes per day (CPD) are the two measures that are most 
predictive of quitting outcomes (Baker et al., 2007; Borland, Yong, O‘Connor, Hyland, & 
Thompson, 2010). The two measures have further been combined into an index known as 




1989). HSI was created from items 1 and 4 of FTND; namely, ―How soon after you wake up do 
you smoke your first cigarette?‖ and ―How many cigarettes do you smoke a day?‖ (Borland et 
al., 2010). 
 
 Early studies from 2007 demonstrated a release of very little nicotine from ECs, however, 
the newer generation ECs are showing higher plasma nicotine levels when used by experienced 
vapers, similar to cigarettes (Farsalinos et al., 2014). While comparing the practice of using ECs 
at baseline and 4-week follow-up, the overall nicotine intake was found to be increased by 79% 
(Hajek et al., 2015). These escalated nicotine levels might cause some concerns among 
researchers and health professionals. The literature describes the relationship between the level 
of addiction and quit attempts by measures of FTCD, HSI, and self-efficacy to stop smoking. A 
secondary data analysis was done amongst 864 highly dependent treatment-seeking smokers 
making a quit attempt (Michael Ussher, 2016). The assessment was done at 4, 6 and 48 months 
post-quit date for the continuous smoking abstinence (Ussher, Kakar, Hajek, & West, 2016). The 
results indicated that cigarette dependence, whether measured by the FTND, or by HSI or non-
HSI components, significantly predicted transient and medium-term smoking abstinence and 
hence shows predictive validity (Borland & Cummings, 2008; Hyland et al., 2006; Ussher et al., 
2016). Four of the studies provided evidence for a negative association between higher 
dependence and a quit attempt (Adkison et al., 2013; Hagimoto, Nakamura, Morita, Masui, & 
Oshima, 2010; Vangeli, Stapleton, Smit, Borland, & West, 2011; Zhou et al., 2009) while two of 
the UK studies that examined the influence of time to first cigarette did not show any 
relationship (West, McEwen, Bolling, & Owen, 2001). Dual users and e-cigarette only users 
indicated less craving for nicotine and dual users reported a higher level of addiction than 
conventional cigarette-only users on FTND scale (Rüther et al., 2015). In addition to the above 
evidence in support of level of addiction scale, a hardening hypothesis also supports evidence for 
EC use. This hypothesis states that when the smoking prevalence moves towards and below 
10%, the remaining smokers become deeply addicted, and therefore, lose the abilities to stop 
smoking without moving into alternative forms of ‗clean‘ nicotine addiction such as e-cigarettes 
(Chapman & Wakefield, 2013). 
 
 The total number of cigarettes smoked per day is a predictor of cessation, as stated 




EC users. Two studies reported a significant decline in the self-reported number of tobacco 
cigarettes smoked per day among dual users since the initiation of e-cigarette use. Etter and his 
colleagues found a CPD reduction from a mean of 23 to a mean of 9 and Farsalinos and 
colleagues found a reduction in median CPD reduction from 20 to 4 (Etter & Eissenberg, 2015; 
Farsalinos et al., 2015). Two US-based surveys reported changes in CPD among dual users since 
the initiation of e-cigarette user (Rass et al., 2015; Rutten et al., 2015). Both found a remarkable 
CPD reduction of 50% and 54%; no change was found in 45% and 41%; and only a few 
presented an increase in CPD (5% and 2%) in both studies (Rass et al., 2015; Rutten et al., 2015) 
with an additional 30% reduction in CPD median. Furthermore, among dual users sample, when 
compared to non-daily users, daily e-cigarette users had a greater reduction in CPD (Rass et al., 
2015). Research evidence also shows specific patterns associated with frequency (Farsalinos et 
al., 2015). A daily intake and a higher frequency of ECs have been shown to be strongly 
associated with quitting when compared with the intermittent use of ECs similarly to any other 
therapeutic or substitute product (Biener & Hargraves, 2015; Siegel, Tanwar, & Wood, 2011). 
Moreover, TTFC has also been found to be helpful in evaluating the harm reduction associated 
with e-cigarette use (Dawkins, Turner, Roberts, & Soar, 2013). Thus, so far the literature focused 
on the level of addiction and CPD among EC-only users without considering the effects on dual 
users. Also, the effect of TTFC has only been studied for tobacco users and not among EC or 
dual users. This study investigated the relationships between the unexplored concepts.  
4. Socio-demographics 
 
The World Health Organization defines social determinants of health (SDH) as ―the conditions 
in which people are born, grow, live, work and age‖ and ―the fundamental drivers of these 
conditions‖ (Commission on Social Determinants of Health, 2008). In order to achieve equity 
and eliminate tobacco-related disparities, tobacco prevention and control approaches seek out for 
interventions that incorporate SDH. A substantial correlation exists between these social factors 
and health behaviours (Fuchs, 2017). A description of the research findings on the prevalence of 







Young adults between the age group of 18-24 years were more likely to smoke ECs for a 
prolonged duration (26.5%), while those aged 25 and above were more likely to be non-users of 
ECs (40%) (Zhuang et al., 2016). Generally, the mean age to start smoking has been found to be 
17 years among post treatment e-cigarette users and 18 years among non-EC users (Curry et al., 
2017). 
b) Gender 
The rates of smoking cessation differ among males and females. The risk of mortality from the 
smoking-attributable diseases has been found to be more common among women (Thun et al., 
2013). Moreover, women exhibit greater reluctance to quit than men (Smith et al, 2016). No 
significant differences have been found in EC use among Canadian males and females of age 15 
years and above. The past 30-day use of e-cigarette was found to be the same for both groups 
(1.8% of Canadians for both sexes) (Czoli et al., 2015). The rate of ever-use of ECs was more for 
males (8.9%) as compared to females (8.1%). However, when calculated within age groups, 
more significant differences were found. For example, a higher prevalence was observed among 
males aged 15-19, and young adults of age 20-24 (23.9% and 24.5 % respectively) who had tried 
e-cigarettes, while only 15.5% and 15.6% of females in both age groups used ECs (Czoli et al., 
2015). This difference could be due to the fact that men tend to engage in risky behaviors more 
than women (Harris, Jenkins, & Glaser, 2006). In contrast, a higher prevalence of EC use was 
observed among females of 25-44 years of age group. Dual-use of cigarettes and EC has also 
been found to be high, as stated earlier, 63.6% of ever-users and 77.7% of past 30-day EC user 
among young adults were found to be smoking tobacco cigarettes simultaneously; whereas only 
15.5% of ever-users and 12.4% of past 30-day users were former cigarette smokers (Czoli et al., 
2015). One of the recent studies show that women are more likely to be persistent EC users 
(51.5%) than men (48.5%), and less likely to be transient or non-users when compared to their 
male counterparts, however, no significant differences were found (Zhuang et al., 2016). 
c) Marital Status 
 
A recent study evaluated the odds ratio for the survey participants who were also smokers. 




Similar rates were found for the respondents who were not married. Therefore, more single and 
married people considered ECs to be harmless (Volesky et al., 2016). Whereas, an equal number 
of participants, who were either separated, divorced or widowed, agreed on both harmless and 
harmful perspective (Volesky et al., 2016). While considering the number of people using EC, a 
US-based study found less number of married people using it in the past 30 days when compared 
to others (Rigotti et al., 2015). 
d) Education 
 
In the aforementioned study, 67.9% of the participants who perceived EC as harmless and 64.5% 
who regarded EC use as harmful were post-secondary educated (Volesky et al., 2016). Thirty-
two percent of the participants who were less than post-secondary educated, in contrast, regarded 
e-cigarettes to be harmless and 35.5% considered EC to be the likely cause of harm (Volesky et 
al., 2016). It was further demonstrated that 26.2% of the former smokers who also had ever used 
e-cigarettes were moderately educated (Czoli et al., 2014). The total number of people, who were 
both current smokers and ever users of ECs, with low education was found to be the highest, 
whereas the number was low for respondents with high education (Czoli et al., 2014). The US 
study established that 15.6% of educated people (with a college degree or more) had used EC in 
the past 30 days as compared to people with less than high-school education (10.2%) (Rigotti et 
al., 2015). Moreover, the people with lower education have lagged behind their higher education 
counterparts in cessation (Zhuang et al., 2015). 
e) Income 
 
The smoking rates have been found to be twice as high for the lower income groups as for the 
higher income groups in Canada (Government of Canada, 2016c). While looking at the 
perspectives, overall, 46% of the people who regarded ECs to be harmless were having a middle 
income range of $40,000- $79,000 followed by 38% with a high income of more than $80,000 
and 31% with an income of less than $40,000 (Volesky et al., 2016). Similar rates were also 
found for the people with harmful perspective. However, the study captured smoking histories 
but did not assess current smoking status and thus the dual-use component was left unexplored 






Among people considering the harmless perspective, 15.7% were unemployed and 84.3% were 
employed, whereas among the people who regarded EC as causing deleterious effects, 17.2% 
were unemployed and the rest 82.8% were employed. Hence, from this study, it was established 
that more employed people think e-cigarettes to be a harmless alternative (Volesky et al., 2016). 
A report further declared that there is no relationship between income and the motivation for e-
cigarette usage. All smokers as participants in the study had a mean household annual income of 
$51,300 and17.2% among them who were dual users had a mean household income of 48,200 
(Doyle et al., 2015). 
g) Ethnicity 
 
The examination of the ethnic factors associated with EC awareness in a study sample found a 
less likelihood of EC awareness among non-White population (South Asian, Chinese, Black, 
Filipino, Latin American, Arab, Southeast Asian, West Asian, Korean, Japanese, Aboriginal or 
multiracial) when compared with White ethnic group's respondents (Shiplo et al., 2015). Ever 
and current use of EC among current smokers was found to be higher among White population 
groups than non-White groups (Czoli et al., 2014). Moreover, the percentage of people in the 
White ethnic population was also found to be high among the sample of former smokers who had 
ever used EC than current EC user (Czoli et al., 2014). 
h) Region 
 
According to 2013 tobacco use report, smoking rates reveal smoking prevalence of 11.4% in 
British Columbia and of nearly 20% in New Brunswick, Newfoundland & Labrador, and Nova 
Scotia (Reid et al., 2015). All provinces except Ontario and British Columbia had smoking rates 
above the national average of 14.6%. A significant difference was exhibited in ever users of ECs 
when categorized by province (p<0.01) (Czoli et al., 2015). The prevalence range varies 
significantly from as low as 5.6% in Ontario to a high of 13.4% in Nova Scotia (Czoli et al., 




C. Cessation interventions 
1. E-cigarettes as cessation aids 
 
ECs have potentially contrasting functions in controlling the rates of tobacco use. These 
functions could further be examined through the lens of cessation, prevention, protection, and 
industry interventions. This section will focus on the role and effectiveness of ECs in cigarette 
smoking cessation. The evidence is still premature regarding the overall potential risks and 
advantages associated with e-cigarettes. The safety concerns of ECs are still uncertain, and 
therefore, this fact should not be neglected. The currently available evidence suggests that ECs 
have around 4% of the relative harm of cigarettes overall (including social harm) and 5% of the 
harm to users (McNeill et al., 2015). 
 Two reviews give strong evidence in support of EC as a tool to stop smoking in the long-
term (>6 months) compared to placebo as per a Cochrane review involving meta-analysis 
(McRobbie et al., 2014; Rahman et al., 2015). Seven percent of the smokers who used nicotine 
ECs were found to quit, in contrast to 6% of the smokers who used nicotine patch and 4% who 
used placebo ECs respectively. However, ECs are not as effective as nicotine patch (McRobbie 
et al., 2014). McRobbie and colleagues also established that ECs are responsible for reducing 
smoker's cigarette consumption by at least half when compared to placebo ECs (ECs without 
nicotine) (95% CI [1.02-1.68]) and nicotine patch. Another study also found ECs to be positively 
associated with smoking cessation (95% CI [0.11-0.28]) (Rahman et al., 2015). Individual 
studies within the remaining reviews reported similar findings (Hajek et al., 2014). Further, 
keeping in context the debate around ECs, a study found 54.8% of smokers who used ECs as a 
substitute were more likely to quit, whereas only 39.6% of the smokers quit who used ECs as a 
complementary aid (Doyle et al., 2015). In addition, the desire to smoke also decreased when 
ECs with or without nicotine were used (Gualano et al., 2015; Hajek et al., 2014). 
 There is evidence suggesting that smoking cessation might get impeded by the use of 
ECs. For instance, Grana and his colleagues claim that EC use is associated with significantly 
lower odds of quitting smoking (OR=0.61, 95% CI [0.50 to 0.75]) (Grana et al., 2014). The 
results are, in fact, different when following different approaches, especially with RCTs. The 




NRTs, while population studies suggest ECs decreasing the likelihood to quit smoking. 
Nonetheless, these contrasting studies had limited review of the literature and hence authors 
caution about insufficient research on the efficacy of e-cigarettes in smoking cessation. Other 
reviews were generally of moderate to poor quality and lacked appropriate evidence to prove 
EC's effectiveness (Grana et al., 2014; Gualano et al., 2015; Manzoli et al., 2015; Rahman et al., 
2015). Thus, more literature review is needed to make definitive conclusions.  
2. Other quit resources 
 
Although e-cigarettes have not been approved by FDA as a smoking cessation aid, there are 
other approved safe and effective measures that could help people quit. Five types of nicotine 
replacement therapy such as patch, gum, lozenge, inhaler, nasal spray and two non-nicotine 
medications; bupropion and varenicline demonstrate healthy effects (CDC, 2017). Along with 
pharmacological interventions, individual, group, and telephone counseling have also been found 
to be effective in helping smokers quit (Perera & Lancaster, 2013; Stead & Lancaster, 2017; 
Ucar et al., 2014). While cessation counseling and FDA-approved cessation medications are each 
effective alone, they are even more effective when used in combination (CDC, 2017). Cessation 
counseling is available free through provincial quitlines (Government of Canada, 2015). Quit 
smoking medications may be available free or at a discount through provincial quitlines, health 
insurance agencies or clinics. 13 provincial and territorial health insurance plans cover quit-
smoking treatments (Government of Canada, 2016a). While the coverage varies by state, all 
states cover some treatments for at least some enrollees. 
 
 The effect of a simple brief advice to tobacco smokers does not show a profound effect 
on cessation rates as found in a study (Stead, Bergson, & Lancaster, 2013). An additional 1 to 3 
% increase of quitting was found if unassisted cessation rate of 2 to 3% is assumed (Stead et al., 
2013). Follow-up visits also provide a beneficial effect on cessation rates (Stead et al., 2013). 
Therefore, more intensive counseling interventions are needed to support smokers. A qualitative 
analysis reveals some of the considerations of health care providers about e-cigarettes. The 
professionals see them as a substitute of one negative health behavior for another. The 
involvement of the healthcare providers to address EC use in preventive measures is thus 
important (Hiratsuka, Avey, Trinidad, Beans, & Robinson, 2015). The healthcare providers need 




the questions raised in favor or against EC use, in order to provide appropriate advice to people 
who smoke (McRobbie et al., 2014). In a recent research, it was found that most family 
physicians do not recommend ECs for cessation due to lack of evidence on the long and short-
term impacts (Ofei-Dodoo, Kellerman, Nilsen, Nutting, & Lewis, 2017).  
 
 Other quit aids such as quit contests hold a promising role at an international level but 
lack a population-level impact (Cahill & Perera, 2008). Acupuncture, laser therapy have not been 
found to be associated with persistent cessation when compared to NRTs. Although they are 
popular interventions and safe when correctly applied. However, they show a low success rate in 
quitting when compared with other evidence-based interventions (White, Rampes, Liu, Stead, & 
Campbell, 2014). 
3. Mobile interventions 
 
Many studies have successfully evaluated the role of mobile phone-based technologies in 
supporting smoking cessation. However, most of this evidence did not consider mobile phone 
application rather was limited to evaluating the efficacy of mobile phone SMS text messaging 
interventions for smoking cessation (Ghorai et al., 2014). Young adults, in fact, have reported an 
interest in more intense mobile-based smoking cessation interventions, such as smart-phone 
applications (apps), compared to other text messages (Naughton et al., 2013; Ybarra et al., 2014). 
Smart-phone apps have the ability to enrich the user experience with more information, 
components, and functionality (Bindhim et al., 2014). Moreover, smoking cessation smart-phone 
apps now have enormous reach compared to quit lines and SMS text messaging interventions 
(Bricker et al., 2014). A high acceptance rate of mobile application in smoking cessation has 
been identified among hospital patients (Finkelstein & Cha, 2016). For these reasons, exploring 
the effectiveness of smart-phone apps is critical. Only two RCTs were found to evaluate the 
efficacy of a smoking cessation mobile phone app. One of them compared a mobile phone 
application to an SMS text messaging intervention for smoking cessation (Baskerville et al., 
2015). One of the factors that are encouraging young adults to use e-cigarettes is the popular 
electronic technology (Stanbrook, 2016). The same factor could be attributed to the increased use 
of smart-phones. Over  90% of the American young adult population own a smart-phone (Smith, 
2015). The CTC study is one of the first studies that conducted a rigorous evaluation of the effect 




adult smokers (Whittaker, McRobbie, Bullen, Rodgers, & Gu, 2016). The present study, 
therefore, would be the first to analyze this rich data with a purpose to achieve the dual user's 
patterns of cessation. Further, no study evaluated the smart-phone application data set to describe 
dual or e-cigarette user's smoking cessation patterns. The present study, therefore, determined the 
prospects mobile applications hold in quitting smoking among dual users of both e-cigarette and 

























Study Rationale and Research Questions 
 
Dual-use of ECs and tobacco cigarettes has been found to be common in population studies 
(Czoli et al., 2015; Shiplo et al., 2015). However, they lacked a comparison group of non-EC, 
transient and persistent EC users. They also did not consider these groups as a distinct 
subpopulation. In addition to that, not many studies have explored the impact of prolonged EC 
use on smoking cessation. Overall, 79% of young adult smokers, of 19-29 years of age, are dual 
users (Czoli et al., 2015). This transitional age to adulthood needs further research to target 
adequate opportunities for preventive actions. The extent to which e-cigarettes could function as 
substitutes or complements will have significant implications for the design and execution of 
policy. Moreover, ECs in studies have been associated with a major challenge of tobacco harm 
reduction (Anthopoulou, 2016). Studies conclude that almost 90% of the smoking cessation 
methods turn out unsuccessful when used as directed (Nitzkin, 2014).  
 Additionally, not much attention has been given to understanding the motivational 
factors, such as social norms, attitudes, self-efficacy, nicotine addiction and cessation support 
services in relation to dual-use and no EC use. The present study, therefore, aided in filling the 
gaps in literature by finding the odds of cessation among these groups and describing the role of 
dual-use in smoking cessation, providing policy makers with a supplement on current premature 
evidence on this controversial issue. 
 The methods chapter discusses the appropriate methodology employed in the study. 
Following that, the results chapter presents the findings of the data analysis. For consistency, the 
research questions were examined in the order given below throughout this dissertation mainly 
focussing on the 30-day cessation outcome. Last, the discussion chapter examines the results 
while making comparisons with previous studies and explains benefits and limitations of the 
study, suggests recommendations for future and provides a final conclusion. The words, 
'abstinence' and 'cessation' have been used interchangeably to define outcome measures. Using 
data from the intake and 6-month follow-up phase of the RCT survey, this dissertation aimed to 




 Research Question 1: Do the rates of smoking cessation (no smoking in last 30 and 7 
days) differ among persistent, transient and non users of e-cigarettes among young adult 
smokers across Canada? 
- Null hypothesis: There is no association between persistent, transient, non users of e-cigarettes 
and smoking cessation rates (30-day and 7-day smoking abstinence). 
 
- Alternate hypothesis: There is a significant association between persistent, transient, non users 
of e-cigarettes and smoking cessation rates. 
 
 Research Question 2 : Do the rates of smoking cessation (no smoking in the last 30 and 7 
days) among persistent, transient and  non users of e-cigarettes differ after adjustments 
for other presumed causes of cessation, including self-efficacy, level of tobacco 
dependence, perceived social norms, use of other quit aids and other socio-demographics. 
- Null hypothesis: There is no association between persistent, transient, non users of e-cigarettes 
and smoking cessation rates (30-day and 7-day smoking abstinence) after adjusting for presumed 
causes of cessation. 
 
- Alternate hypothesis: There is a significant association between persistent, transient, non users 
of e-cigarettes and smoking cessation rates (30-day and 7-day smoking abstinence) after 


















This study involved the secondary analysis of self-reported, longitudinal data collected from 
young adult smokers across Canada. The participants were part of the Crush the Crave (CTC) 
mobile smoking cessation application randomized controlled trial. Briefly, the Crush the Crave 
RCT is one of the few longitudinal surveys which examined the rates of cessation using a smart-
phone application (Whittaker et al., 2016). As a result of the design of the survey, it was possible 
to examine information about smokers before and after they quit, thus enabling examination of 
the research questions pertaining to who quits amongst e-cigarette and non-e-cigarette users, and 
how their social and economic characteristics, personal quit aids usage, and psychological 
characteristics were related to cessation rates over a period of 6-months. Figure 1 illustrates the 
conceptual design of the study and highlights the key measures of interest. It should be noted that 
this study involved an experimenter delivered intervention and randomization of individuals to 
two different treatment conditions (self-help materials and CTC mobile application). A detailed 
description of the CTC study, including study sample, measures and analyses is provided in the 
sections that follow. The study received ethics clearance from the Office of Research Ethics 
(ORE #22215), the University of Waterloo on April 25, 2017. 
 










6-month follow-up survey 
Study measures
Smoker's category (EC use/not)














B. Crush the Crave application 
 
Crush the Crave (CTC) is a smartphone-based smoking cessation application that was first 
developed in the year 2012 by a group of population health researchers, computer programmers 
and experts in social media at the Propel Centre for Population Health Impact, located at the 
University of Waterloo, Ontario. It is a mobile Health (mHealth) intervention which has been 
designed as an evidence-informed smoking cessation application that could easily be used by 
young adult smokers (Baskerville et al., 2015). Following its introduction, the first pilot test was 
conducted on 300 smokers that revealed positive results for its application in terms of 
engagement and use. CTC enables users to choose a quit date or customize their quit plan by 
either quitting completely or reducing their cigarettes smoked per day and also allow users to 
track their health improvement status and financial expenditures saved. Reinforcement in the 
form of rewards is provided to the users for their successful quit attempts, and success may be 
shared with friends or family through social networks and other communities formed on media 
websites. The application also provides support to the users in evaluating their craving triggers 
and psychosocial characteristics through the use of graphs and tables. Moreover, it includes 
features such as notifications, reminders to facilitate real-time monitoring of the data about the 
use of the app and other functions which help smokers to successfully quit. These properties 
make it a suitable and promising intervention to increase user engagement (Baskerville et al., 
2015; Bricker et al., 2014) and have been documented to be associated with successful quitting 
(Civljak, Stead, Hartmann-Boyce, Sheikh, & Car, 2013).  
 
C. Crush the Crave Study Design and Intended Outcomes 
 
A 6-month, two-arm, parallel randomized controlled trial was conducted for the purpose of 
evaluating the mHealth intervention, Crush the Crave, for young adult smokers (Baskerville et 
al., 2015). For the purpose of assessing the effectiveness of the CTC application, the participants 
were randomly assigned into two groups. Half of the participants were allotted to a group that 
used CTC application and the other half used other self-help guide materials, "On the Road to 
Quitting" (Health Canada, 2012b). Investigators, data collectors, as well as the participants, were 
all blinded to the group assignments. The high-quality RCT design and well-assessed structure of 




smoking cessation intervention for young adult smokers. The participants in both groups were 
first asked to complete the baseline or intake questionnaire. The baseline survey first included 
questions about individual socio-demographic characteristics; age, sex, marital status, ethnicity, 
education, income and employment status (Refer to Appendix A1). In addition to these socio-
demographics, smoking behavior information (including amount smoked, the number of quit 
attempts, time to first cigarette) was also collected from the consented participants. Information 
about psychosocial variables (self-efficacy, social norms, attitudes) was also included. Further, 
other cessation support service questions included whether they used e-cigarettes or any other 
quit aid.  
 
 After 3 and 6 months, participants were followed and were asked a similar set of 
questions. However, these were more detailed and incorporated questions about past 3-month 
and 6-month smoking history respectively. The 6-month survey included questions on smoking 
abstinence in the last 30 and 7-days (Refer to Appendix A2-A3). Additionally, the final survey 
asked in-depth questions about e-cigarette use that included EC use history, ever use of EC with 
nicotine, amount smoked, the frequency of use, and reasons for use. A modified Dillman method 
(Hartmann-Boyce, Lancaster, & Stead, 2014) for the online survey questionnaires was used. If 
the participants did not complete the online questionnaire within 2 weeks of the 3-month and 6-
month survey, then they were followed for up to 10 attempts (email and telephone).  
Questionnaires were also pilot-tested with a convenience sample of young adult smokers. 
 
 The randomized controlled trial used the 30-day point prevalence abstinence as the 
primary outcome measure to assess the effectiveness of CTC app in smoking cessation after 6 
months of use. It was assumed that the intervention group would have high 30-day point 
prevalence smoking cessation as compared to the people in the control group using self-help 
materials (Baskerville et al., 2015). The secondary measures that were examined included a set 
of behaviors: 7-day point prevalence abstinence, CPD reduction, the number of quit attempts, use 
of the app at 3 and 6 months intervals, the effectiveness of CTC in promoting the use of other 
cessation supports. The study also examined possible mediators to cessation, including 
psychosocial factors such as self-efficacy, social norms, attitudes, social support and stress 
(Baskerville et al., 2015). Overall, the study primarily focused on the effectiveness of the 




present study is based on CTC study and performs an in-depth analysis of the dual users, e-
cigarette and non-e-cigarette users and measures the odds of quitting amongst those groups. 
 
 The CTC data provides a fairly comprehensive picture of the young adult smoker's 
characteristics and their individual level responses. One of the assets of each survey phase is that 
it amasses a rich dataset useful for describing complex behavior. Moreover, the longitudinal 
measurement of smokers allows the establishment of temporal relationships between measures 
otherwise not observable with cross-sectional designs. Further, the RCT is one of the few 
longitudinal studies analyzing the rates of cessation among young adult smokers Canada-wide 
using a smart-phone intervention, making the data useful for exploring the role of dual-use of e-
cigarettes and tobacco cigarettes in smoking cessation. 
 
 In order to ensure adequate reporting and to evaluate validity and applicability, a 
CONSORT-EHEALTH (Consolidated Standards of Reporting Trials of Electronic and Mobile 
HEalth Applications and onLine TeleHealth) checklist was developed (Eysenbach & 
CONSORT-EHEALTH Group, 2011). The RCT protocol was implemented in conformity with 
expectations of the checklist. Refer to Figure 2 for a CONSORT-EHEALTH diagram of the 
study design.  
 
D. Participants and Recruitment 
 
Young adult male and female smokers across Canada were selected for the RCT study 
(Baskerville et al., 2015). Participants were enrolled into the study if they were between the ages 
of 19 and 29, were current smokers, residents of Canada, had intended to quit smoking in the 
next 30 days, had an Android or iPhone OS mobile phone, were able to provide informed 
consent and were able to comprehend English language. In order to avoid any incidence of an 
unintended exposure of participants to either the intervention or control group, it was determined 
that the respondents were not referred to the study by an existing study participant (for example 
by a friend or family member already participating in the study). This criterion thus avoided 
possible contamination bias which, if incorporated, may have minimized or accounted the 
differences in outcomes between the two groups. The complete CTC data intake form is 













































Quit rates, EC use, quit attempts, 
self-efficacy, use of quit aids, 
feedback on interventions used. 
 
n=851 (total) 
Telephone follow up 
Submitted 3-month 
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Canadian everyday smokers, age 19-29 
years, intending to quit, fluent in 
English, not referred by another study 
participant, have an android / iphone / 
mobile phone 
n=2670  
excluded (not meeting 
inclusion criteria/failed 




 The eligibility criteria questions included: 'In the last 30 days, how often did you smoke 
cigarettes?', 'On average, how many cigarettes do you smoke each day?', 'When was the last time 
you smoked a cigarette, even a puff?', 'Do you intend to quit smoking within the next 30 days?', 
'What is your date of birth? ' (to check whether they fall within 19 to 29 years age group), current 
age, 'Are you comfortable understanding, reading, and speaking English?', 'Are you aware of 
anyone in your household (besides yourself) who is participating in this study?'.  
Figure 3 - Illustration of the recruitment process 
 
Source - (Baskerville et al., 2015) 
 
 Participants were recruited over a period of 32 weeks using both online and offline media 
channels such as Facebook, Kijiji advertisements and classified newspaper ads respectively 
(Refer to Figure 3). The enrolled young adults were referred to a website that explained the trial 
and also screened for their eligibility. A total incentive of $35 was provided for participation and 
completion of the surveys. In addition, the participant's name was entered into a draw at the end 
of the study (Spring 2015), for an iPad 2 Air 64GB. An informed consent was acquired during 
the intake survey wherein 1599 young adult smokers got screened. They were randomly 
allocated to either the CTC (intervention) or self-help intervention (control) (Refer to Figure 2-
3). 
 Randomization was done using a 1:1 allocation ratio and a computer-generated 
procedure. The groups, however, were balanced based on sex, age and cigarette consumption. As 
the participants were unaware of the intervention group allocation, they were blinded until the 
completion in addition to the data collectors and investigators. After completing the initial 
survey, smokers were re-contacted every three months for up to 6 months to complete follow-up 
surveys. Longitudinal survey respondents lost to attrition were not compensated. 
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 All RCT recruitment and data collection procedures were reviewed and cleared by the 
Ethics Review Boards at the University of Waterloo on October 29, 2013, ORE No. 19275. 
E. Survey Inclusion and Retention Rates 
  
A total of 4,269 participants were found to be eligible for the study. Out of these, 2,670 (62.5%) 
participants were excluded due to various reasons; non-compliance with the inclusion criteria, 
incomplete intake surveys, participation refusal, multiple participation attempts or absence of 
contact information. Recruitment retention rates across the three phases of the RCT have been 
described in Table 1. Amongst all the eligible participants recruited in the RCT, more than thirty-
five percent (1,599) met the eligibility criteria. The cohort submitted either intake, 3-month or 6-
month follow-up survey. This research is limited to those 53% people who successfully 
submitted their surveys during the intake and 6-month survey. Thus 851 is considered as the total 
sample of the current study (Refer to Table 1).  
 
 




# People who started the survey 
 
 
# People who submitted the 
survey 
 
Retention  % agea 
Intake  1599 
 
1599 100% 





936 851 53.2% 
Intake + 6-month follow-up 















Selected CTC measures used in the present study are described below, beginning with how the 
smoking cessation was defined, followed by a description of the e-cigarette use exposure 
variable, and socio-demographics, personal usage and psychological variables (covariates 
anticipated to affect the relationship between the outcome measure and independent variable). 
The following theoretical and operational definitions of the variables were used in this study. 






Table 2 - Theoretical and operational definitions of dependent and independent variables 







Dichotomous (0,1) The proportion of former 
smokers who have not smoked 
in the last 30 days, typically at 
the time of assessment. 
Participants not having smoked 
any cigarettes, even a puff, or 
used other tobacco products in 






Dichotomous (0,1) The proportion of former 
smokers who have not smoked 
in the last 7 days, typically at 
the time of assessment. 
Participants not having smoked 
any cigarettes, even a puff, or 
used other tobacco products in 


























People using ECs for a long 
period of time. 
 
 
People using ECs for a short 
period of time. 
 
 
People not using e-cigarettes 
Current users of either nicotine 
-containing or nicotine-free e-
cigarette (daily, once in a week 
or once in the last 30 days) 
during the 6-month survey. 
 
Participants who were current 
users of e-cigarettes at both 
intake and follow-up survey. 
 
Participants who were current 
users of e-cigarettes only at 
intake or only at follow-up.  
 
Participants who did not use e-









Ever EC but no 
nicotine 
 




Never EC users 
 
People who ever tried or used e-
cigarettes containing nicotine in 
their life. 
 
People who ever used EC that 
did not contain nicotine. 
 
People who ever tried or used e-
cigarettes that contained 
nicotine. 
 
People who never used ECs. 
 
Participants who ever tried or 
used e-cigarettes with or 
without nicotine. 
 
Participants who ever used EC 
that did not contain nicotine. 
 
Participants who ever tried or 
used e-cigarettes that contained 
nicotine. 
 
Participants who never used 
ECs.  
Note- Each independent variable was regressed separately with other predictors to check for any association in Bivariate and Multivariable regression models (refer to Table 5-7). 
 
1. Outcome measures 
 
(a) Primary outcome measure 
Self-reported 30-day smoking abstinence (non-smoking) at 6-month follow-up was considered as 
the primary outcome measure. The current study examined the longitudinal effects of e-cigarette 
use on smoking cessation, therefore, only responses from the 6-month (final) phase of the survey 
were considered in the analysis. The definition of "non-smoking" was operationalized as not 
having smoked any cigarettes, even a puff, or used other tobacco products in the last 30 days 




cigarette users were compared separately for their smoking abstinence rates. The primary 
outcome measure for the original study was also self-reported (Baskerville, Struik, & al, 2015). 
The response to the final survey question, 'Have you smoked any cigarettes or used other 
tobacco, even a puff, in the last 30 days?' (final_q3), was used to identify individuals who quit 
tobacco cigarettes and those who did not (Refer to Appendix A3). People answering 'No' to the 
question were coded as quitters and the others as smokers. People answering 'Don't know' or 
'Refused' were considered as missing. 
 
 Complying with SRNT (Society for Research on Nicotine and Tobacco) subcommittee 
recommendation on biochemical verification for large sample size studies involving low-
intensity interventions, biochemical validation was not deemed necessary as no added benefit has 
been found in terms of determining the smoking status (Benowitz et al., 2002). 
 
(b) Secondary outcome measure 
Self-reported 7-day smoking abstinence at 6-month follow-up was considered as the secondary 
outcome measure. 7-day smoking abstinence was determined using responses to the question, 
'Have you smoked any cigarettes or used other tobacco, even a puff, in the last 7 days?' 
(final_q4) at 6-month follow-up survey. People who responded 'No' were defined as quitters and 
the others as smokers. As the people answering 'No' to 30-day smoking abstinence question 
stated above were also nonsmokers in the last 7 days, they were also merged with the people 
answering 'No' to the 7-day smoking abstinence question and hence they all were coded as 7-day 
quitters. 
 
2. Independent variables 
 
(a) E-cigarette use 
 
E-cigarette use was determined using a combination of responses to the question asked during 
the baseline and 6-month follow-up survey respectively, 'Which of the following quit supports 
have you used in the past or are you currently using? - E-cigarettes' (intake_q30d_curr), and 'In 
the last 30 days, how often did you use electronic cigarettes (e-cigarettes, vaporizer)?' 
(final_q39) respectively. The people who marked 'using currently' for the former question and/or 




latter were considered as E-cigarette users. Following the definition of Zhuang et al., based on 
the length of EC use, smokers were further subclassified into three categories:  
 Persistent e-cigarette users were those who were current users of e-cigarettes at baseline 
and follow-up.  
 Transient e-cigarette users were those who were current users of e-cigarettes only at 
baseline or only at follow-up.  
 Non-e-cigarette users were those who did not use e-cigarettes at either baseline or 
follow-up.  
 
 Among the 6-month follow-up respondents, current EC users were further classified 
based on their frequency of use. The frequency of ECs was assessed by the question: 'In the last 
30 days, how often did you use electronic cigarettes (e-cigarettes, vaporizer)?' (final_q39). Based 
on user's responses, participants were further classified as 'daily', 'once in a week', 'once in last 30 
days' and 'non users'. Those answering 'not at all' and those who did not respond to this question 
were referred to as 'non users'. 
(b) Ever E-cigarette with Nicotine users  
Ever use of e-cigarettes that contained nicotine was assessed by a combination of responses to 
the questions; 'Have you ever tried or used an electronic cigarette (e-cigarette, vaporizer)?' 
(final_q33) and 'Have you ever tried or used an electronic cigarette (e-cigarette, vaporizer) that 
contained nicotine?' (final_q35), asked at the final phase of the survey. For the former question, 
people answering 'Yes' were identified as 'Ever E-cigarette users' and those responding 'No' were 
classified as never EC-users. People who answered 'Yes' to both the questions, then they were 
classified as "Nicotine EC users" (i.e. they had ever used ECs and also e-cigarettes that contained 
nicotine). Alternatively, if they answered 'Yes' to the former and 'No' to the latter question then 
they were identified as "Ever without nicotine users" (i.e. they had ever used ECs but without 
nicotine). The remaining people who answered 'No' for both were classified as "Never users".  
3. Other independent predictors 
 
(a) Socio-demographics - Age, Gender, Marital Status, Education, Income, Occupation, 





Questions about participant's socio-demographics were asked in the intake survey. Respondents 
were asked about their age, gender, marital status, education, income, occupation, ethnicity, and 
region (intake_currentage, intake_q31 to intake_q37) (Refer to Appendix A1). Age included a 
numerical answer; gender category included male, female, transgender and 'others' responses; 
and, the marital status question asked for participant's current status which included options as; 
Single (never legally married), Married, Common Law, Separated (but still legally married), 
Divorced, Widowed. Later, for the purpose of analysis, age was collapsed into two groups; 19-23 
and 24-29 years; gender was collapsed into male or female categories excluding transgender and 
'others' as they were found to be less than 1%. Marital status was sub-classified into single and 
married. Married and common-law were combined into one category, 'Married'. Other options of 
separated, divorced, widowed were not included as they were less than 2%. For education, 
respondents were asked, 'What is the highest level of education you have completed?.' 
Respondents could choose from the following response categories: Less than high school; High 
school diploma, certificate, or equivalent; Some postsecondary education without a degree, 
certificate, or diploma; Registered apprenticeship or other trades certificate or diploma; College, 
CEGEP, or other certificate or diploma; University degree. This education variable was later 
collapsed into a variable describing individuals with some degree (diploma, college, or 
university) and those without. 
 
 Income categories were collapsed into four categories; less than $15,000; $15,000-
$44,999; $45,000-$79,999;  $80,000- $120,000 for analysis. Occupation categories included Yes 
(full-time, part-time, on paid leave, on paid sick or disability leave, on unpaid leave), No 
(student, unemployed, others that included pregnancy reasons, on Ontario Disability Support 
Program, part-time student or do seasonal/shift work). Ethnicity question asked, 'Which 
population group do you identify with?' for which answers included a range of population groups 
such as Aboriginal, Arab, White, Chinese, South Asian, Black, Filipino, Latin American, 
Southeast Asian, Japanese, West Asian, Korean or Other. However, only three categories 
Aboriginal, White and Non-White (combining all other groups) were specified for the analysis 
due to the small sample size. Due to similar reasons, the region was collapsed into only two 
categories Ontario and other provinces (British Columbia, Alberta, Saskatchewan, Manitoba, 
Quebec, New Brunswick, Nova Scotia, Prince Edward Island, Newfoundland and Yukon, 





(b) Psychological variables - Self-efficacy, Social norms, Level of Addiction (Cigarettes per day 
and Time to First Cigarette) and Quit attempts 
 
(i) Self-efficacy  
 
Self-efficacy, as defined earlier, is the concept that an individual believes in their personal ability 
to perform the intended behavior (McAlister, Perry, & Parcel, 2008). This effect was assessed by 
the response to the following question asked both in the baseline and final survey: "On a scale 
from 1 to 5 with 1 being 'not at all' and 5 being 'extremely', how confident are you in your ability 
to quit smoking?" (intake and final_q17) (Refer to Appendix A1). Later, for the purpose of 
analysis, the categories were merged into 3 categories; low, moderate and high self-efficacy. 
Information about respondent‘s temptations to smoke in different situations (with friend, in the 
morning, in stress, over coffee, for lift, while angry, with close friend smoking, not smoked for a 
while, while frustrated and while over the phone) (intake and final_q18a to q18j) were collected 
at both the baseline and follow-up survey according to the five-point scale of SASEQ. The self-
efficacy among the persistent, transient and non-users of ECs, who had not quit smoking at the 
final survey, were compared across both the baseline and 6-month follow-up surveys. This was 
done to identify differences in the levels of self-efficacy among smokers only so as to prevent 
any bias developed due to the presence of quitters, who might have already developed high self-
efficacy at follow-up. Alternatively, the frequency analysis for different situations was only 
conducted for the intake survey as follow-up survey respondents also included people who had 
quit. For the purpose of model building, only baseline self-efficacy was included in the model as 
the individuals who had quit were highly motivated with high self-efficacy and whose inclusion 
might have biased the results.  
(ii) Social Norms, Attitudes and Beliefs 
 
Social norms, attitudes and beliefs about smoking were assessed by the response to the following 
question asked in the baseline survey: 'What is your overall opinion of smoking?' (intake_q19). 
Participants could respond with one of the following options: very positive, positive, neither 
positive nor negative, negative and very negative. These answers were later coded into either 
positive, neither or negative. For the purpose of model building, only baseline social norms and 





 Respondents were also asked to agree or disagree with some statements that indicated 
their opinions about smoking, such as; 'I worry that smoking will damage my health in the 
future', 'My friends disapprove of smoking', 'Society disapproves of smoking', 'Cigarette smoke 
is dangerous to nonsmokers', 'Smoking helps people stay slim', 'Smoking helps people feel more 
comfortable at parties and in other social situations', 'Smoking helps reduce stress', 'Smoking can 
help people when they are bored', 'My family disapproves of smoking' (Refer to Appendix A1, 
q19-28), that were later coded and frequency analysis was performed.  
 
(iii) Level of Addiction 
 
The level of nicotine addiction was measured by the Heaviness of Smoking Index (HSI) 
(Heatherton et al., 1989) which was derived from the number of cigarettes smoked per day 
(CPD) and time to first cigarette (TTFC). 
 
Cigarettes per day  
The number of cigarettes smoked per day (CPD) is an indicator of a person's level of addiction. 
At baseline, all were everyday smokers and the study calculated a CPD indicator using 
respondents‘ answers to the following questions: 'On average, how many cigarettes do you 
smoke each day?' (intake_q2) from the baseline questionnaire which had categorical options 
from '1' to '29' corresponding to the number of cigarettes consumed in a day along with the 
category number '30+' indicating more than 29 CPD. Four categories were formed; 1-10, 11-20, 
21-29, 30 and more.  
 
Time to First Cigarette 
 
The time to first cigarette, an additional measure of addiction, was collected from respondents‘ 
answers to the question 'How soon after you wake up do you smoke your first cigarette?' 
(intake_q10) in the baseline survey with four options of 'Within 5 minutes', '6 to 30 minutes', '1 
to 60 minutes', 'More than 60 minutes'. Respondents could indicate the amount of time between 
waking and the first cigarette from amongst these options. Short self-reported time values (within 
5 minutes) have been associated with high levels of nicotine dependence, while long values of 
more than 60 minutes have been associated with low levels of nicotine dependence (Heatherton 





 The heaviness of smoking index was calculated by adding CPD and TTFC. Smokers with 
high CPD and less than 5 minutes of TTFC were given the highest smoke-index score whereas 
people who smoked between 0-10 cigarettes and had high TTFC were allotted the lowest score. 
The level of addiction or dependency were analyzed next with four categories: lowest (with least 
smoke-index score), low, high, highest (with highest smoke-index score). 
 
(iv) Quit attempts 
 
Information about a respondent‘s attempts to quit smoking was collected from a combination of 
responses asked from the final survey: 'In the past 6 months, how many times did you stop using 
tobacco for 24 hours or longer?' (final_q7) which included numerical categories from 1 to 180 
with each number corresponding to the number of quit attempts made in the last 6 months. This 
question was only asked from people who had made a quit attempt for at least 24 hours. 
Therefore, people who made at least one quit attempt were then further compared with people 
who answered 'No' to the question; 'In the past 6 months, did you stop smoking for at least 24 
hours because you were trying to quit?' (final_q6). Hence, quit attempt was defined as the 
percentage of people who made at least one quit attempt in the last 6 months. 
 
(v) Use of other Cessation Supports and Interventions 
 
Participants, at intake survey, were asked about any other quit support they might have used in 
the past or were using currently (intake_q30a to q30o). People either marked 'using currently' or 
'used in the past' for different cessation supports that included Telephone Quitline/support, 
Nicotine replacement therapy (NRT) products (e.g. gum, patch, inhaler), Prescription cessation 
medications (e.g. Wellbutrin or Champix), Health professional advice (e.g. doctor, pharmacist), 
Group cessation programs, Self-help materials, Quit smoking contests, Quit smoking websites, 
Quit smoking smartphone apps, Social media sites (Facebook/Twitter/Instagram), Hypnotherapy, 
Herbal therapy, Laser therapy or any other supports. People who were current users of any of the 
aforementioned quit aids at intake survey were defined as quit support users while others were 
identified as non users.  
 
 Participants were asked in the 6-month follow-up survey if they had downloaded the 




Appendix A3, q46). Those answering 'Yes' were identified as intervention users while other were 
considered as non-users. 
 
Other covariates analyzed for frequency analysis include:  
 
(a) Reasons for using Electronic Cigarettes 
 
The 6-month follow-up survey participants who were e-cigarette users were asked about the 
reasons for their current use of e-cigarettes. The reasons included 'they are affordable', 'they are 
fun to use', 'they taste good', 'Using e-cigarettes might help me to quit smoking', 'they might be 
less harmful to me than cigarettes', 'they might be less harmful to people around me than 
cigarettes', 'I can use e-cigarettes in places where smoking isn't allowed', 'other reason (specify)' 
(Refer to Appendix A3, final_q43 to q43g, final_q43i). Frequency analysis was conducted 
among EC users for the different reasons cited that were then followed by the assessment of 
persistent and transient EC users' perceptions. 
 
G. Sample Size and Power Calculations 
 
Power and sample size calculations were done using G*Power v 3.1. Since literature has not 
identified the effect size for this type of study, sample size calculations were calculated assuming 
an α of .05, β =.95, and using Cohen's effect size convention for a medium effect of 0.15 for 
multiple regression. The required sample size was found to be 845 participants. Hence, the 
current study sample of 851 participants provided sufficient power to detect a medium-sized 
effect regarding the association between e-cigarette use and smoking cessation rates while 
adjusting for covariates (Kraemer & Kupfer, 2006). The value of 0.15 for effect size is a 
moderate, reasonable and conservative size based on other research (Szucs & Ioannidis, 2017) 




All analyses were conducted using SAS software, Version 9.3 of the SAS Studio, University 
Edition System for Windows. Copyright © 2012-2016 SAS Institute Inc. Prior to analysis, the 
survey data was cleaned and reviewed for any unusual values or patterns which could affect the 




had submitted the three phases of the RCT survey, it was further filtered to get only the 
participants of the intake and 6-month follow-up survey. Following which variables were 
developed to perform in-depth analysis. SAS automatically dropped the missing values for the 
outcome measures out from the analysis. As multiple imputation method could only be applied 
to larger missing data samples (Bennett, 2001; Schafer, 1999), it was not applied in this study.  
 
 Frequency analysis was conducted for all the aforementioned predictors. Group 
comparisons were also made amongst persistent, transient and non-e-cigarette users to determine 
any level of association with cessation. Odds ratios, associated confidence intervals, and p-values 
were calculated for all covariates included in the model. Significance levels for both the initial 
bivariable and multivariable logistic regression analysis were fixed at a level of significance (α) 
of 0.05 and a confidence interval (CI) of 95%. The analyses consisted of four steps. 
1. Descriptive Statistics – Univariable and Bivariable analysis 
 
Frequency tables were generated as a first step, to describe the distribution of data in terms of 
socio-demographics (i.e. age, gender, marital status, education, occupation, income, region, and 
ethnicity) and baseline personal usage characteristics (use of quit aids and CTC/self-help 
intervention) and psychological variables (self-efficacy, social norms, level of nicotine addiction, 
quit attempts). The frequency distribution was obtained for each e-cigarette user category 
(persistent, transient and non-users). Using contingency tabulations and the Pearson chi-square 
(χ
2
) test, socio-demographics, personal usage and psychological variables were explored to 
identify any level of association.  
2. Bivariable Logistic Regression Analysis 
 
To test study hypotheses, a series of logistic regression models were run. The data was analyzed 
using bivariable logistic models between the dependent variable (30-day smoking abstinence) 
and the primary independent variable of e-cigarette use. Along with this model, other series of 
models were generated for nicotine containing EC use category and for other covariates 
separately to examine the relationships with 30-day smoking abstinence (Refer to Table 5-7 for 
results). In order to avoid any overlapping, each of the e-cigarette user's category was modelled 
separately. The unadjusted odds ratios (OR), the 95% confidence intervals (CI) along with their 





 A categorical set of variables were defined for e-cigarette use as persistent, transient and 
non-users with 0 for non-users and 1 for transient and 2 for persistent users. Dummy variables 
were also specified for the outcome variable of quitting (0,1); 0 for people who did not quit and 1 
for people who quit smoking.  
3. Multivariable Logistic Regression Analysis 
 
A multivariable logistic regression model was specified to examine the unique combination of 
factors for identifying the most significant variables in explaining smoking cessation. This full 
entry model included all psychological and quit support usage variables and only significantly 
associated socio-demographic variables that were found to be conceptually relevant (Refer to 
Figure 8) with quitting (p<0.05) from bivariable analyses for any level of the variable. Adjusted 
odds ratio (AOR), 95% CI and p-values were examined to assess the significance of the 
relationships.  
 
 Bivariate and multivariable regression analyses were conducted separately for EC users 
at 6-month follow-up survey based on the frequency of its use. Four dummy variables were 
created for the people using ECs daily, once in a week, once in the last 30 days and non-users.  
 
4. Sensitivity analysis of the Predicted Models 
 
PROC LOGISTIC was used to calculate concordance index (c-statistic) and construct Receiver 
Operating Characteristics curves (ROC curves), which are useful for evaluating the accuracy of 
predicted models: the larger the area under the curve of the ROC curve the more predictive the 
model is (Hajian-Tilaki, 2013). ROC curves were constructed for both the bivariable and 
multivariable models and then were compared for accuracy.  
 
I.  Resources and Funding 
 
The University of Waterloo and the Propel Centre for Population Health Impact provided 
assistance with the required resources and detailed information about the RCT study. In addition, 
the School of Public Health and Health Systems at the University provided assistance with 
installing a well-equipped software for data analysis. The preliminary study received funding 
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A total of 851 (53.2%) respondents from both the intake and 6-month follow-up cohorts 
successfully completed the online survey questionnaire and were included in the preliminary 
frequency analysis. Of these respondents, 837 (98.4%) answered the question on quitting 
smoking in the last 30 days. Therefore, for the purpose of evaluating smoking abstinence, those 
14 participants (1.6%) were excluded from this analysis because their quitting response was 
either "don't know" or "refused" which could not be classified with confidence as quitting 
smoking. Therefore, for model building, the final sample consisted of 837 participants who had 
either responded 'Yes' or 'No' to the question on whether they had smoked any tobacco cigarettes, 
even a puff, in the last 30 days.  
 
A. Missing Data 
 
About 2% of the complete dataset under study was considered missing as participants either 
responded "don't know" or "refused" to the question on quitting smoking. For the secondary 
outcome measure similarly, about 2% of the data was missing (including don't know/refused). 
Among covariates, although some variables such as income, occupation and ethnicity had more 
than 2.5% missing data values, for others the total percentage of missing responses was very low 
(less than 2%). All missing frequency and percentages for both the baseline and 6-month follow-
up survey variables are presented in Appendix B1.  
 
 All 851 respondents were included in the frequency analysis but for the purpose of 
finding answers to study's research questions, only 837 people were included in the models. 
Although the literature does not provide any limiting value regarding an acceptable missing 
percentage for producing valid statistical inferences, it has been claimed that missing data of less 
than 5% is insignificant (Schafer, 1999) and others have suggested that a missing percentage of 
more than 10% may lead to biased results (Bennett, 2001). Therefore, with only 2% missing data 
for the outcome measures, bias was insignificant and there are unlikely to be systematic 





B. Proportion of Dual, E-cigarette and Non E-cigarette users 
 
The results of one-way frequency analysis for e-cigarette and non-e-cigarette users are presented 
in Figure 4. At intake, of the total sample size, there were 16% (n=136) dual users and 84% 
(n=715) of non-EC users. The total number of dual users continuing to smoke e-cigarettes and 
non-EC users taking up e-cigarettes when followed from baseline to 6-month follow-up survey 
has been presented in Figure 4. The total number of people using e-cigarettes increased to 286 
(34%) at 6-month follow-up survey.  
 
 








     Persistent E-cigarette users (68)      Transient E-cigarette users (284)   Non-users (488) 
Note: 95% CI is shown in parenthesis for each estimate. 
  
 
 At follow-up, EC use was defined by the frequency of use either daily, once a week or 
once in the last 30 days, as practiced by Westling and colleagues (Westling et al. 2017). More 
than half of the baseline dual users continued to smoke e-cigarettes at follow-up (CI [42.6%-
59.4%]). These respondents formed almost 8% of the total sample (n=68) and were considered as 
persistent users. Thirty-one percent of those who consumed only cigarettes at intake survey 
started using e-cigarettes by 6-month follow-up survey (CI [27.6%-34.4%]). Hence, 33.4% of the 
total sample who were using e-cigarettes at follow-up and not at intake, and who were not using 
e-cigarettes at intake and not at follow-up were defined as transient e-cigarette users (n=284). 
The other 57.3% of the total sample (n=488) were referred to as non-e-cigarette users. 
 
 The proportion of people quitting (30-day smoking abstinence) among all the three 
groups, has been described in the bar graph (Refer to Figure 5). Thirteen percent (n=9) of the 
Non E-cigarette 
users (N= 715 ) 
Dual-users 










users (N= 218) 
Non E-cigarette 
users (N= 488) 
Non E-cigarette 
users (N= 66) 
E-cigarette 




persistent users quit smoking at 6-month follow-up survey while 23% of the transient EC users 
(n=66) did not smoke even a puff in the last 30 days. In comparison, almost 29% of non-users of 
e-cigarettes quit at 6-month follow-up. A significant association was found between e-cigarette 
smoker's categories and 30-day smoking abstinence (χ
2
=8.73, p<0.05). Therefore, when the quit 
rates among the three smoker's categories are defined in an ascending order; persistent EC users 




Figure 5 - Distribution of 30-day smoking abstinence among e-cigarette users and non-users 
 





 The chi-square tests also revealed statistically significant differences between overall EC 
users (that combined both persistent and transient users) and non EC users for the rates of 30-day 
smoking abstinence (χ
2
=6.16, p<0.05), with 21.3% of the EC users and 29% of the non users 
quitting at 6-month follow-up survey.  
 
 A weak association was found between 7-day point prevalence abstinence and dual-use. 















































follow-up survey whereas 68% did not quit. More than 34% (n=97) of the transient EC users did 
not smoke cigarettes (even a puff) for the last 7 days. Amongst non-users, a slightly higher 
percentage of almost 39% quit smoking and 61% did not quit in the last 7 days (Refer to 





C. Socio-demographics of E-cigarette and Non E-cigarette users 
 
Personal attributes of the final sample by e-cigarette use are presented in Table 3. The mean age 
of 24 years was similar across all the three groups of persistent, transient and non users. On 
average, persistent EC users had smoked 13 cigarettes per day (SD=6.61) whereas transient e-
cigarette users had smoked 14 cigarettes per day (SD=8.4) and non-users had smoked 12 CPD 
(SD=7.4).  
 
 A strong association was found between age and e-cigarette smoker category. More than 
half of the e-cigarette users (53%) were more likely to be in the younger age group of 19 to 23 
years when compared with non-e-cigarette users who had a higher percentage of people in the 
age group of 24 to 29 years (57%) (p<0.05) (Refer to Table 3). For both EC and non-EC users, 
more than half were male and approximately two-thirds of the sample were not married. 
Persistent EC users had more people (63%) with a university degree than transient and non-EC 
users. A quarter of the persistent users had a higher income of $80,000 or more. More than a 
third of the participants in all three groups had an income of $15,000-$49,999. Employment 
status was almost the same across all the groups with almost 70% being employed and the other 
30% unemployed. Furthermore, it was found that more than three-quarter of e-cigarette users 
belonged to the white ethnic group (77%) as compared to the non-user group with 72.3%. 
Nonetheless, no notable association was found between the socio-demographics described above 
except age and region. More than 80% of the persistent users lived in regions outside of Ontario 
and a χ
2
 test revealed a significant relationship between region and smoker categories (χ
2
=20.47, 







Table 3 - Personal characteristics of e-cigarette and non-e-cigarette users 



















































































































































































































































222 (80%) 188 (39.7%) 135.90 
<0.01 
 
Note. The values presented have been derived from the participants who completed intake and 6-month follow-up survey, N=851. 
a Not all totals are the same because of missing data on some variables 
 b Comparison made using χ
2






D. Self-efficacy and Social norms among E-cigarette and Non-E-cigarette users 
 
At baseline, almost half of the participants had a moderate self-efficacy. Comparisons made 
between high and low self-efficacy shows that more persistent EC users (42.4%) had a high 
confidence to quit smoking. More people under transient EC user group category (18%) showed 
to have low self-efficacy to quit smoking whereas very few people amongst persistent users 
(12%) had low self-efficacy. 
  
 Considering only people who were smokers at 6-month follow-up survey, significant 
results for self-efficacy were found for e-cigarette users categories (Refer to Table 4). Twenty-
seven percent of the persistent users at baseline survey had high self-efficacy to quit smoking, 
9% had low self-efficacy and the others had moderate self-efficacy to quit smoking. Whereas, 
the percentage of persistent users having high confidence to quit escalated to 68% at 6-month 
follow-up survey (χ
2
=15.5, p<0.01). Alternatively, transient EC users (45%) and non-users (42%) 
had more people having low self-efficacy at follow-up survey (χ
2
=13.5, p<0.01 and χ
2
=30.6, 
p<0.01 respectively).  
 















































    
aNot all totals are the same because moderate self-efficacy values have not been presented.  
bComparisons made separately among dual users (persistent, transient EC users) and non-users, for high, moderate and low self-efficacy, using χ
2
tests, between intake and 6-
month follow-up survey. p-value at α=0.0. 






 A frequency analysis was conducted to check for the proportion of people with high or 
low temptations for smoking in a particular situation at intake survey. It was found that more 
than half of the participants, in situations (Refer to Appendix C1); when out with friends, in 
stress, when angry or frustrated and when out with a spouse or close friends, were more tempted 
to smoke cigarettes. When group comparisons were made across persistent, transient and non-
users, it was found that non-users were highly tempted to smoke when out with friends. 
However, more persistent EC users had high temptations to smoke in the morning (χ
2
=10.34, 
p<0.05), in stress, over coffee, in need of lift (χ
2
=10.90, p<0.05), when angry, with spouse/close 
friend, when not smoked for a while, frustrated and while over phone, than non-users and 
transient EC users. However, only associations with 'morning' and 'in need of lift' situations were 
found to be significant. 
 For the social norms among participants at intake survey, a weak association was found 
across all the three groups. An overall negative opinion of smoking was found to exist among all 
groups but this number was the least among people using ECs for a prolonged period of time 
(64%) when compared to transient users (73%) and non-users (69%). However, no statistical 
significance was found (χ
2
=3.24, p=0.52). The frequency analysis for different statements 
defining social norms (Refer to Appendix C2), revealed that the majority of the participants 
believed in smoking damaging their health in the future with more than 91% of participants in all 
the three groups agreeing to the statement. Around 85% percent of the participants across the 
three groups held an opinion that cigarette smoking is dangerous to non-smokers. Almost 25% of 
the participants believed that 'smoking helps people stay slim' and more than two-thirds agreed 
with the statement that 'smoking helps reduce stress'. While 28% of the non-EC users believed 
that their friends had a negative opinion about smoking, 59% of them believed that smoking 
makes them feel more comfortable at parties and social situations. More than 60% of the people 
believed that 'smoking can help people when they are bored'. Additionally, 63% of the non-users 
had a strong opinion about their family disapproving smoking. However, amongst all the 
statements, only one significant relation was found to exist when examined in a contingency 
table between the three smoker's categories and the beliefs (agree, neither and disagree) about 




statement, and 56% and 61% respectively of long and transient EC users agreeing to the 
statement (χ
2
=11.4, p<0.05).  
 
E. Ever E-cigarette use with Nicotine, Level of Dependence and Quit attempts 
 
The follow-up survey found a total of 472 (56%) participants who had ever used e-cigarettes 
containing nicotine while 128 (15%) participants had ever tried or used e-cigarettes without 
nicotine. Moreover, there were 2% ever EC users who did not know whether they used nicotine-
containing ECs or not. These results might be biased as the answers were self-reported and the 
respondents might be unaware of their e-cigarette's composition. Twenty-seven percent (n=227) 
of the respondents had never used e-cigarettes in their life.  
 The level of nicotine dependence was determined by the sum of cigarettes per day (CPD) 
and time to first cigarette (TTFC) at baseline. Overall, almost a quarter of all the smokers at 
baseline showed a lower level of dependence to nicotine cigarettes (n=626, 74.4%) whereas only 
25.7% showed to have a higher dependency. Most participants among EC users reported being 
less addicted to cigarettes (70%). However, when compared to non-users (22%), more EC users 
(30%) were found to have a higher addiction (χ
2
=7.23, p<0.05).  
 The mean number of cigarettes smoked per day (CPD) was found to decline among 
smokers (n=619) from baseline (M=13.2, SD=8.1) to 6-month follow-up survey (M=8.1, 
SD=8.9). A paired t-test revealed a statistically significant two-tailed p-value of less than 0.01. 
Similarly, significant results were found for all the smoker's category. All smokers under groups 
of persistent, transient EC users and non-EC-users showed to have a statistically significant 
reduction in their cigarettes smoked per day (Refer to Appendix B2).  
 One-way frequency analysis found a relatively weak association to show that over 92% 
transient EC users had made at least one quit attempt in the last 6 months followed by non-users 









F. Use of Other Cessation Supports 
 
In one way frequency analysis, it was found that more than three-quarter of the sample had used 
either of the cessation supports at intake, that included; telephone quit-line, NRTs, prescription 
medications, health professional's advice, group programs, self-help materials, quit contests, 
websites, smartphone applications, social media sites, hypnotherapy, herbal therapy and laser 
therapy. A strong association was found between persistent EC use and use of other cessation 
supports (χ
2
=13.2, p<0.05). More persistent users were using other quit supports (37%) when 
compared to transient (17.6%) and non-users (19%).  
 
 Taking a deeper look into the most prevailing quit aid used among the different smoker's 
categories, it was found that NRT use was most prevalent among transient EC users with more 
than 6% using them at baseline. Only 2% of persistent e-cigarette users used NRT (χ
2
=10.4, 
p<0.01) (Refer to Appendix D). Similarly, the use of health professional's advice (HPA) was also 
statistically significant across the three groups. More persistent users (10.3%) were users of HPA 
at baseline when compared to transient and non-users (both 3%) (χ
2
=9.7, p<0.01). Among those 
who quit in the last 30 days, use of e-cigarette (26.5%) surpassed that of NRT (12.4%) (χ
2
=13.2, 
p<0.01). However, other cessation supports of self-help materials, contests, medicines, websites, 
group cessation programs, applications, hypnotherapy, herbal therapy, and social groups did not 
reveal any statistically significant association. 
 
G. Abstinence among E-cigarette and Non-E-cigarette users 
 
The frequency analysis of primary and secondary outcome measures showed that there were 218 
(26%) participants in total who reported 30-day point prevalence abstinence from smoking 
tobacco cigarettes. An additional 11% (n=309, 37%) were found to represent 7-day abstinent 
from smoking. The frequency and percentage of reported abstinence lasting at least 30 days and 




Bivariate and multivariable logistic regression analysis established significant relationships 
between 30-day smoking abstinence and smoker's categories of e-cigarette use, and e-cigarette 




smoking abstinence are presented in Table 5 for the sample of people who completed intake and 
the 6-month follow-up survey. The table presents the total number and percentage of participants 
who remained abstinent from smoking.  In addition to that, it also describes both bivariable and 
multivariable models for the significant rates of cessation by smoker's category, and by other 
predictors of socio-demographic, psychological and quit aid/intervention usage variables that 
have further been defined by odds ratio (point estimates), confidence interval and p-value.  
 
 The results of the logistic regression analyses for the 30-day smoking abstinence have 
been described more in detail in the following sections, starting with a description of the 
bivariable and multivariable model results for all the eight socio-demographic, four 
psychological and two quit supports usage characteristics, followed by a detailed explanation of 





Twenty-seven percent of the young adults, between 19 to 23 years of age, were found to remain 
abstinent from smoking in the last 30 days and 24% of the young adults, belonging to 24 to 29 
years of age, remained abstinent. Three percent more females (27%) than males abstained from 
smoking. Similarly, 3% more people with no university degree compared to people with a 
university education, were found to quit smoking in the last 30 days at 6-month follow-up 
survey. However, no significant association for the 30-day smoking abstinence was found with 
age, sex, education, marital status, income, occupation or region (Refer to Table 5). The models 
assessing individual predictors (bivariable association) found a weak association for respondents 
belonging to the Aboriginal and other ethnic groups. Aboriginal people were 1.5 times more 
likely to quit than White ethnic group (OR=1.44, 95% CI [0.88-2.35], p=0.16). However, no 
significance was achieved in either of the models. Thus, ethnicity was the only variable (amongst 
socio-demographics) that was included in the final model, when establishing associations with 
the smoker's category defined in Table 5, as all the other characteristic variables were found to 
have a statistically insignificant association in the preliminary bivariable model.  
 The full set model (multivariable) included only statistically significant socio-
demographic variables and not others as they are distal factors and would not directly influence 





Thirty percent of the people with high self-efficacy at intake survey remained abstinent for 30-
days at 6-month follow-up survey (n=101). On bivariable logistic regression analysis, a 
statistically significant relationship was found between 30-day quitting (30-day smoking 
abstinence) and baseline self-efficacy. Smokers with high self-efficacy were almost 2 times more 
likely to quit (OR=1.73, 95% CI [1.08-2.8], p<0.05) (Refer to Table 5). Thus, being a strong 
predictor, the variable of self-efficacy was carried forward to the final model. The multivariable 
model, that adjusted for ethnicity, and all other predictor variables (social norms, quit support 
use, nicotine dependence, quit attempt and intervention use), revealed a strong statistically 
significant association between high self-efficacy and quitting (AOR=1.92, 95% CI [1.14-3.21], 
p=<0.05).  
 In either of the models, no statistically significant association was found between 
baseline social norms and quitting (Refer to Table 5). An overall positive or negative opinion 
about smoking did not show any significant association with quitting rates (OR=1.05, 95% CI 
[0.37-2.9], p=0.93). With a weak association, people who did not make any quit attempts were 
1.3 times more likely to quit (OR=1.33, 95% CI [0.81-2.2], p=0.26). Moreover, the level of 
dependence also did not show any sign of association with the primary outcome measure of 
interest. For the purpose of evaluating relationships between independent variables and outcome 
measures, the multivariable model included all the four psychological variables irrespective of 
their significance levels due to the reason of their possible proximity to the outcome (Refer to 
Figure 8).  
Use of intervention or quit aids 
In both bivariable and multivariable models, the odds ratio was found to be the same for the 
people using any quit support, CTC intervention or self-help intervention. No statistically 
significant relationship was found between abstinence and use of quit supports or the 
intervention. The multivariable model controlled for all the predictors that defined the use of 






Table 5- Bivariate and multivariable logistic regression for the association between e-cigarette users' categories, other 






Abstinent na (%) 
Bivariateb 
Involving Single Predictor 
Multivariablec 
Involving Multiple Predictors 
OR crude 95% C.I. p-value OR adjustedc 95% C.I. p-value 
(a) Smoker's category 








































































No university/college degreed 









































































































































































(d) Quit aid and Intervention use 


































    
CI = Confidence Interval; OR = Odds Ratio, p-value at 0.05 level of significance. 
aNumber and percent of participants who were abstinent at 30 days at 6-month follow-up in each category.  
bBivariable analysis: series of models that assessed association of e-cigarette user category, all socio-demographics, psychological and usage characteristics individually with 30-day smoking abstinence.  
cConfounders included in Multivariable analysis: ethnicity, baseline variables (quit aid_current use, self-efficacy, social norms, nicotine dependence) and 6-month variables (quit attempt, intervention user) 
Following regression equation in PROC LOGISTIC: Y =  x1+  x2 + x3 + x4 + x5 + x6 + x7 + x8 + 𝛽0 (constant), where Y= 30-day smoking abstinence and x1= EC use, x2= ethnicity, x3= self-efficacy, x4 = 









} = 𝛽0 + 𝛽1𝑥1+𝛽2𝑥2 + 𝛽3𝑥3 + 𝛽4𝑥4 + 𝛽5𝑥5 + 𝛽6𝑥6 + 𝛽7𝑥7 + 𝛽8𝑥8  
# Variables not included in the final Multivariable model. 






Smoker's category  
E-cigarette use 
 
Over 29% of the non-users of e-cigarettes quit smoking for the last 30 days when compared to 
only 13% of the persistent EC users and 23% of the transient EC users quitting. A significant 
relationship was found between this independent variable of EC use and 30-day smoking 
abstinence. People not using e-cigarettes were 2.6 times more likely to quit than people using e-
cigarettes for a longer duration (OR=2.62, 95% CI [1.26-5.43], p<0.01). However, a relatively 
weak association was found between transient and persistent EC use and 30-day quitting 
(OR=1.95, 95% CI [0.92-4.2], p=0.08).  
 The multivariable analysis found a strong association between quitting and EC use, with 
people not using ECs being 3 times more likely to quit smoking than persistent users (AOR=3.2, 
95% CI [1.4-7.4], p<0.01). Moreover, transient users were also two times more likely to quit 
than prolonged EC users (AOR=2.4, 95% CI [0.99-5.9], p<0.01).   
 The comparisons made for the rates of cessation based on the frequency of e-cigarette use 
among 6-month follow-up current e-cigarette users, found that non-users were almost three times 
more likely to quit than people who used e-cigarettes within the last 30 days (OR=2.64, 95% CI 
[1.5-4.6], p<0.01). While people who used e-cigarettes daily or once a week were two times 
more likely to quit than people who used e-cigarettes once in last 30 days (p<0.05 for both). 
Similar results with a high level of significance were found after controlling for other predictors 
(ethnicity, psychological, quit aids usage factors)  (Refer to Appendix E1).  
 
Ever EC with nicotine use 
Only 19% of the young adult ever users of nicotine containing e-cigarettes, remained abstinent 








Table 6 - Bivariate and multivariable logistic regression for the association between e-cigarette with nicotine use, other 







Involving Single Predictor 
OR crude (95% CI) 
p-value 
Multivariablec 
Involving Multiple Predictors 
OR adjusted (95% CI) 
p-value 
Ever Nicotine EC use 
Nicotine EC userd 





















    
CI = Confidence Interval; OR = Odds Ratio, p-value at 0.05 level of significance. 
aNumber and percent of participants who were abstinent at 30 days at 6-month follow-up in each category.  
bBivariable analysis: series of models that assessed association of e-cigarette with nicotine use, all socio-demographics, psychological and usage characteristics individually with 30-day smoking 
abstinence.  
cConfounders included in Multivariable analysis: ethnicity, baseline variables (quit aid_current use, self-efficacy, social norms, nicotine dependence) and 6-month variables (quit attempt, 
intervention user) 
Following regression equation in PROC LOGISTIC: Y =  x1+  x2 + x3 + x4 + x5 + x6 + x7 + x8 + 𝛽0 (constant), where Y= 30-day smoking abstinence and x1= EC use with nicotine use, x2= 









} = 𝛽0 + 𝛽1𝑥1+𝛽2𝑥2 + 𝛽3𝑥3 + 𝛽4𝑥4 + 𝛽5𝑥5 + 𝛽6𝑥6 +  𝛽7𝑥7 + 𝛽8𝑥8  
dReference group. 
 
 The odds ratios for quitting as predicted by each of the EC with nicotine user types are 
presented in Table 6. When looking at the single effects in bivariable modeling, PROC 
LOGISTIC produced statistically significant results between quitting and never EC users and, 
between quitting and EC without nicotine users. The bivariable logistic regression analyses 
revealed a strong relationship for those who had never used e-cigarettes with odds of being 
abstinent 2.5 times more than those who had ever used or tried e-cigarettes containing nicotine 
(OR=2.54, 95% CI [1.78-3.63], p<0.01). Similarly, the results of PROC LOGISTIC bivariable 
regression models indicated that ever EC users (that did not contain nicotine) had odds twice that 
of nicotine EC users for quitting (OR=1.85, 95% CI [1.82-2.88], p<0.01).  
 The multivariable logistic regression also established significant results between never 
EC use and 30-day smoking abstinence (AOR=2.92, 95% CI [1.98-4.30], p<0.01), implying that 
never-users are three times more likely to quit smoking than ever nicotine EC uses, after 
adjusting for all the other relevant predictors. Likewise, ever non-nicotine EC users were also 






Table 7 - Association between e-cigarette user category and smoking cessation outcomes 
Outcomes Favorable outcomea 
n (%) 
OR crudeb (95% CI) OR adjustedc (95% CI) 
Primary outcome 
   30-day abstinence 
      Persistent usersd 
      Transient users 
















Secondary outcome  
   7-day abstinence 
      Persistent usersd 
      Transient users 
      Non-users    
 
 














CI = Confidence Interval; OR = Odds Ratio. 
aNumber and percent of participants who obtained favorable outcomes at 6-months follow-up survey in each group.  
bBivariable model that assessed association of EC use (persistent, transient and non-users) individually with 30-day smoking abstinence.  






Bivariable and multivariable logistic regression analysis produced significant relationships 
between e-cigarette with nicotine use and 7-day smoking cessation. However, no statistically 
significant results were produced with either persistent or transient users. For all the other 
predictors, similar results were obtained as for the 30-day smoking abstinence (Refer to 
Appendix E2). The summary of the findings from the logistic regression analyses predicting 7-
day smoking abstinence along with 30-day abstinence is presented in Table 7 for the sample of 
people who completed intake and follow-up 6-month survey. The detailed results of the 
bivariable and multivariable regression analysis are presented in Appendix E2. 
H. Goodness of fit in Logistic Regression 
 
 The concordance statistic is a measure of goodness of fit for binary outcomes in logistic 
regression. The values are presented in Figure 6 which provides information about the area under 
the ROC curves. C-statistic, as in clinical studies, gives the probability that a randomly selected 
participant who quit had a higher odds score than a participant who had not quit. This measure is 
useful for evaluating the accuracy of predicted models. The larger the area under the curve of the 
ROC curve the better predictive power the model has (Hajian-Tilaki, 2013). ROC curves were 




compared for accuracy. As shown in Figure 6, the multivariable model for EC use category has 
the largest area under the curve value (c-statistic) signifying that is it the most accurate model 
amongst both the models defined. Only the primary outcome measure of 30-day smoking 
abstinence was assessed for sensitivity analysis.   
 
Figure 6 - ROC curves for  e-cigarette user category 
Bivariablea Multivariableb 
  
aBivariable associations established associations between E-cigarette use and 30-day smoking abstinence.  
bConfounders included in Adjusted model: ethnicity, baseline variables (quit aid_current use, self-efficacy, social norms, nicotine dependence) and 6-month variables (quit 
attempt, intervention use) 
 
 Further statistics to measure the usefulness of the model is the generalized R
2 
(coefficient 
of determination) value. The value for the final multivariable model was found to be 0.43. The 
maximum value that R
2 
attains is less than 1 (Bewick, Cheek, & Ball, 2005). The R
2 
statistics do 
not measure the goodness of fit of the model but indicate how useful the explanatory variables 
are in predicting the response variable. The value of 0.43 indicates that the model is useful in 
predicting the quitting outcome. 
I. Reasons for E-cigarette use 
 
People who were current users of e-cigarette at 6-month follow-up survey answered the question 
about their perceptions on e-cigarette use. As illustrated in Figure 7, out of 286 (33.6%) people 
who were current users of e-cigarettes, the most important reason cited for use of ECs was the 
perception that it helped in quitting smoking (67%); other frequent reasons for the use were the 
perceptions that it causes less harm to them (51.8%) and causes less harm to people around 





 When comparing the perceptions of persistent and transient e-cigarette users, it was 
found that 71% of the persistent users and 66% of the transient EC users perceived e-cigarettes 
as a quit aid (χ
2
=5.70, p<0.05). Similarly, 62% of the persistent users and 49% of the transient 
users believed that ECs causes less harm to them (χ
2
=10.7, p<0.01). Therefore, the persistent 
users were more likely to believe that e-cigarettes help in quitting and pose less harm. Similarly, 
significant associations were found for the reasons of ECs being 'tasty' (χ
2
=4.0, p<0.05) and 
'affordable' (χ
2
=3.7, p<0.05). No level of significance was achieved with 2x2 contingency tables 
for other reasons. It should be noted here that no question was asked about perceptions at 
baseline, therefore, transient users that are considered here are the ones who were not using e-
cigarettes at baseline but were using at 6-month follow-up survey (n=218) (Refer to Appendix 
C3). 
 


















Less harm to me
Less harm to people around
Used in restricted areas







The aim of the current study was to better understand e-cigarette use among young adult smokers 
in the context of smoking cessation and also to find any potential association of cessation with 
socio-demographic, psychological and other quit aids usage characteristics. E-cigarette use has 
been found to be controversial in promoting or preventing quitting (Curry et al., 2017; 
Zawertailo et al., 2017, Zhuang et al., 2016). According to several strong studies (McRobbie et 
al., 2014; Rahman et al., 2015) , e-cigarette use should increase the likelihood of quitting, in this 
case, 30 and 7-day abstinence. Although this is not the first study to examine the prevalence of e-
cigarette use and quitting, this longitudinal study to my knowledge, is the first to examine the 
persistent use of e-cigarettes and its association with quitting outcomes in a sample of Canadian 
smokers.  
 
 The results show that dual users who continued to use ECs persistently across the course 
of study, were less likely to quit smoking in the last 30 days when compared to non-users even 
after controlling for other relevant predictors. This study examined data from the longitudinal 
component of  Crush the Crave RCT Survey - a Canadian survey of young adult smokers, to 
identify the rates of 30-day and 7-day point prevalence abstinence, along with examining 
proximal outcome measures of cessation behavior.  
  




Overall, 12.4% of young adult Canada-wide smokers who quit for the last 30 days were found to 
have been using both e-cigarettes and conventional tobacco cigarettes. Further, 34.4% of people 
who quit in the 6-month follow-up survey were either long or transient e-cigarette users.  More 
than half of the baseline dual users were still using e-cigarettes six months later and 31% of those 
who consumed only cigarettes at the intake survey started using e-cigarettes by 6-month follow-
up survey. These findings are consistent with previous research findings (Curry et al., 2017; 
Zhuang et al., 2016). This increased uptake of e-cigarettes among smokers needs further 




associated with using e-cigarettes (Yu et al., 2016), the majority of the persistent users (57%) 
perceived e-cigarettes as a quit aid and perceived them to be posing less harm to them. These EC 
perceptions, as mentioned in previous studies, could potentially lead to social ―normalization‖ of 
smoking behaviours (Fairchild, Bayer, & Colgrove, 2014; Peters, Meshack, Lin, Hill, 2013). The 
proportion for the age of study participants was somewhat similar to CTADS results. The present 
study had 47% of the smokers in the 19-23 years of age group and 38% of the smokers in the 24-
29 years of age group were found to be using e-cigarettes. The majority of the persistent users 
belonged to regions outside of Ontario. The study had a higher percentage (56%) of ever-EC 
with nicotine users when compared to only 26% from the Statistics Canada report (Statistics 
Canada, 2017). However, the percentage of people who were unsure about the nicotine content 
was less (only 2%) in the current study. The study results were also consistent with a recent 
study (Rüther et al., 2015) about the level of self-efficacy and level of addiction showing that 
people using ECs had a high self-efficacy to abstain from smoking but at the same time, they had 
a comparatively higher level of addiction to nicotine than non-users. However, the mean number 
of cigarettes smoked per day was found to decline among dual users from baseline mean of 13 to 
follow-up mean of 8, which is similar to some previous studies (Etter & Eissenberg, 2015; 
Farsalinos et al., 2015). The self-efficacy levels were found to escalate among persistent EC 
users whereas the levels reduced for non-users. Moreover, persistent EC users were also more 




Canada does not currently encourage smokers to use e-cigarettes to help them quit smoking due 
to the lack of strong evidence, whereas the situation differs in the UK where one e-cigarette 
company has recently received approval for marketing them as cessation aids (McKee, 2016; 
Olov & Bridgman, 2014). People who did not use e-cigarettes were more likely to quit smoking 
in the last 30 days compared to people who were using e-cigarettes. This finding adds to the 
growing body of evidence on EC use and cessation (Borderud, Li, Burkhalter, Sheffer, & 
Ostroff, 2014; Pearson et al., 2015; Vickerman, Carpenter, Altman, Nash, & Zbikowski, 2013; 
Zawertailo et al., 2017). The results of the present study could be a part of the other studies that 
links persistent use of ECs to the risk of delayed quitting. These results are similar to findings 




among e-cigarette users (Borderud et al., 2014; Curry et al., 2017; Zawertailo et al., 2017). 
However, these studies included participants that were either cancer patients, only belonged to 
Ontario who were a part of a smoking cessation program that included behavioral counselling 
and use of NRTs or were the participants of a community-based cessation trial. Two studies, 
similar to the present study, assessed 7-day smoking abstinence at 6-month follow-up survey 
(Borderud et al., 2014; Zawertailo et al., 2017) and the other assessed 12-month smoking 
abstinence  (Curry et al., 2017). The findings of the present study are also contrary to a recent 
study done by Zhuang et al. that assessed 3-month follow-up quit rates among the US population 
group of adults of more than 18 years of age (Zhuang et al., 2016). These population studies thus 
imply that ECs could have a significant impact on reducing the rates of quitting or they are being 
increasingly used by failed quitters. Unlike previous research (Doyle et al., 2015; Hajek et al., 
2014; Rahman et al., 2015; Zhuang et al., 2016), a weak relationship was found between e-
cigarette use and quitting in the last 7 days. Although 7-day cessation may be a useful measure 
for comparisons over the course of time, North American Quitline Consortium (NAQC) 
recommends 30-day quitting as the primary measure for reporting on outcomes (NAQC, 2010). 
Therefore, irrespective of the results found, the study provided additional evidence on persistent 
e-cigarette use and 30-day abstinence.  
  
 Thus, the significant differences in the rates of cessation between persistent, transient and 
non EC users answers the study's research question 1 and rejects the null hypothesis. The 
statistical significant differences in cessation rates between persistent, transient and non EC use, 
even after adjusting for presumed causes of cessation (socio-demographics, psychological and 
quit usage characteristics), answers the study's research question 2 and hence rejects the null 
hypothesis. 
 
 Past studies have been criticized for excluding people who used e-cigarettes and then 
successfully stopped smoking (McNeill et al., 2014; Science Media Centre, 2016). This study 
described e-cigarette use and cessation rates among participants who intended to quit smoking 
upon enrollment and took baseline and follow-up survey use into account. Dual users who 
continued to use ECs throughout the survey contributed to a 50% increase in the rate of smokers 
using other quit aids when compared to transient EC users and non-users. This suggests that 




too. Moreover, the study represented transient users being the most predominant group giving 
the advantage of detecting any impact of using e-cigarettes on smoking cessation which previous 
studies lacked due to the unbalanced e-cigarette grouping. The likelihood of baseline e-cigarette 
users turning to persistent e-cigarette use seems to be high (51%). It is not clear if this rate of 
transition to persistent use applies to any novice e-cigarette users as we do not know what 
proportion of e-cigarette users at baseline survey would have qualified as persistent users 
already.  
 
 The study also established that people using e-cigarettes had lowered quit rates which 
align with previous studies (Curry et al., 2017; Grana et al., 2014; Vickerman et al., 2013). 
Previous studies have reported an association between higher smoking cessation rates and the 
intensity of e-cigarette use (i.e. daily use) (Chen, Zhuang, & Zhu, 2016; Hitchman, Brose, 
Brown, Robson, & McNeill, 2015). Similarly, the present study also found a positive association 
between daily intake of e-cigarettes and smoking cessation when compared with people who 
used e-cigarettes once in the last 30 days. Similarly, the number of people not using ECs at 
follow-up were also positively associated with quitting, however, the quitting percentage was 
comparatively higher when compared to people using ECs daily. Overall, non-users were 
significantly more likely to quit than e-cigarette users within the last 30 days. Similarly, those 
who used for a transient period were also more likely to quit smoking when compared with 
persistent EC users. This suggests that e-cigarette use for a short period promotes smoking 
cessation while a persistent use, overall, has a negative rather than a positive impact on cessation.  
 
 People with high baseline self-efficacy were more likely to quit at follow-up. This finding 
was congruent with previous studies that showed a higher success in cessation among smokers 
with high confidence to quit (Baldwin et al., 2006; Chouinard & Robichaud-Ekstrand, 2007). 
However, this was not the case for persistent EC users who had high self-efficacy at follow-up. 
These group of people were found to be less likely to quit smoking. These contradictory results 
might be due to a delayed increase in self-efficacy of people while using ECs for a prolonged 
duration. These persistent users might not have been ready to quit smoking at that point of time. 
Further longitudinal studies designed for a longer duration of more than 12 months are in need to 




would be needed in future studies to confirm whether they have a higher self-efficacy to abstain 
than dual users and cigarette-only users, as found in a previous study (Rüther et al., 2015).  
 
 There is a need to treat e-cigarettes in a comprehensive manner that is consistent with 
how traditional cigarettes are approached. Considering the exponential growth of e-cigarettes as 
a smoking cessation aid coupled with aggressive marketing by tobacco companies, healthcare 
providers are increasingly engaging smokers in conversations relating to the use of e-cigarettes 
(Egnot, Jordan, & Elliott, 2017; Shin et al., 2017). The present study findings suggests clinicians 
against recommending e-cigarettes as a treatment product for tobacco dependence, which aligns 
with the American Academy of Pediatrics (AAP) position paper that called for stricter regulation 
of ECs (Farber, Walley, Groner, & Nelson, 2015). HCPs also need to make smokers aware about 
the current 'inconclusive' evidence on the effectiveness of ECs as a cessation tool. From the 
findings, the role of self-efficacy appears to be important and behavioural interventions could be 
helpful to increase people's self-efficacy to quit smoking.  
 
 
Cohort study design and causality 
The contribution of this cohort study confirms a direction for further investigation, and provides 
an evidence to support the association between e-cigarette use and lowered quit rates among 
smokers. The secondary analysis of the existing data provided a cost-effective way to assess the 
association of EC use with quitting. The methods developed for this study utilized the primary 
RCT data in the best way to identify relationships. The results, however, cannot confirm  a 
cause-and-effect relationship between the persistent use of e-cigarettes and smoking cessation. 
Although the results established significant associations between no EC use and quitting even 
after  adjusting for presumed causes of cessation, causality cannot be inferred with confidence. 
Due to the lack of information about e-cigarette use and due to the short duration of only six 
months under consideration in the longitudinal study design of the RCT, the data could not 
assess intensity and frequency of EC usage. The temporal relationships could have been derived 
from the fact that e-cigarette uptake started from the baseline survey which led to quitting after 
the short-term follow-up survey. Also among these transient users, it might be possible that 
people started using ECs after quitting at 6-month follow-up survey. Therefore, there is a need to 




frequency of use, dose and other characteristics over a longer duration of time. Another 
important consideration would be to biologically validate the findings for the nicotine content 
intake. Intentions to quit in the next six months was one of the inclusion criteria for the 
recruitment in the preliminary study. In order to explore motivation, new studies could 
incorporate an index that measures the strength of interest to quit smoking or the intention levels. 












 An additional support for a causal hypothesis is evidenced by an epidemiological 
sensibility and analogy to other well-established relationships (Daya, 2003). There are proximal 
and distal factors which could affect directly and indirectly, respectively, an individual's 
behaviour to quit smoking (Lynch & Bonnie, 1994). The proximal factors included in the present 
study are psychological (self-efficacy, social norms, level of dependence, quit attempts) and quit 
aids usage characteristics (cessation supports and intervention use) which provide a strong 
influence on quitting behaviours. Whereas, the distal factors are the socio-demographic factors 
that are more stable (Flay, Snyder, & Petraitis, 2009) (Refer to Figure 8) that increases the 
relevance of the proximal factors. E-cigarette use might act as a catalyst or an inhibitor between 
the proximal factors and the outcome of quitting. Thus, the factors that were closely associated 
with the outcome were included in the final full-set model. 
 







Age, Gender, Marital status, 
Education, Income, 
Occupation, Ethnicity, Region 
Micro-level (Proximal 
Factors) 







Self-efficacy, Level of 







There are limitations related to the study method and design which need to be considered in the 
interpretation and application of study results. First, the data lacked depth as could be seen by the 
lack of detailed information about e-cigarette use in the baseline survey. The operational 
definition of e-cigarette use, derived from both the intake and 6-month follow-up survey, lacked 
detailed EC usage questions during the intake survey leading to some missing information about 
the frequency, nicotine content and perceptions. Moreover, people using e-cigarettes either every 
day, once in a week and once in last 30 days were merged into one category due to the small 
sample size. These definitions might have differed when considering these three categories 
separately. For example, persistent or transient EC users using e-cigarettes daily might have had 
different rates of cessation than weekly or once in last 30 days users. There might be a 
misclassification bias for non-users of nicotine-containing e-cigarettes. Some might be unaware 
of their EC's composition as the illegal marketing of e-cigarettes has also been reported in 
Canada, although no evidence exists for the proportion (Shiplo et al., 2015). Without knowledge 
of nicotine content in their e-cigarette, it is possible that a larger proportion of individuals may 
have inadvertently reported being non-users of nicotine ECs which might have biased the results 
pertinent to quit rates. However, given the large proportion of smokers who indicated ever EC 
use and later proceeded to report not having nicotine in their ECs, the definition of EC with 
nicotine amongst the respondent sample may be closer to the hypothetical operational definition.  
 
 Second, it is possible that different rates of abstinence may occur if the current 
respondents were observed over a longer period of time. There may be delayed effects of e-
cigarette use which are currently not observable during a six-month period (Farsalinos, Tsiapras, 
Kyrzopoulos, Savvopoulou, & Voudris, 2014). As it is a longitudinal study, missing data is a 
common problem encountered which could cause a significant impact on the validity of the study 
and the ability to draw accurate inferences (McKnight, McKnight, Sidani, & Figueredo, 2007; 
Rubin, 1976). Some of the participants of the RCT study had dropped out of the study before six 
months and thus did not successfully complete all the three phases of the survey. Due to the low 
retention rate, there was missing data for certain variables of interest. As validity was of 
importance, the approach of analysing only complete cases was adopted for analyzing the data. 
In addition, ROC curves used for finding the validity of the prepared models helped in 
establishing a substantial agreement with respect to the direction of relationships between the 





 The study relied on self-reported answers which might have been affected by memory 
bias. Evidence also shows that people might give inaccurate or false answers which could pose 
challenges to the validity of the study, although, in a large sample study, no huge effect on the 
results has been found (Fan, 2006). The close-ended answers to questions on sensitive issues like 
EC use status, tobacco quit attempts, level of addiction and utilization of cessation services might 
have led to some bias in responses because of social issues and perceived stigma. There is a 
possibility of social desirability bias in self-reported tobacco use behaviors. Alternatively, self-
reported answers in this survey offers many advantages too. It enriches the information, 
motivates the participant to report, engages the respondent's identity, offers practical advantages 
of being inexpensive and efficient (Pauhus & Vazire, 2007). Furthermore, no validation by other 
more objective means was done, such as measurement of cotinine levels in those who said they 
had quit as SRNT subcommittee has identified no added benefit in terms of determining the 
smoking status (Benowitz et al., 2002). These secondary data sources provided with a vast 
amount of information, but quantity is not synonymous with appropriateness. These limitations 
not-with-standing, this study adds to the limited literature that has examined smoking 
abstinence among dual users smoking over time.  
 
 Despite the limitations stated above, the findings of this study, with a sample of Canadian 
smokers and a longitudinal study design, shed light on the issue of the dual-use of cigarettes and 
e-cigarettes. The secondary data analysis conducted in this research will be one of a kind in the 
field of e-cigarette research. It offers several advantages because of its secondary nature as it 
saves cost, time and offers a relatively easy way to monitor change over time. Apart from that, 
data is rich in quality as it was funded by renowned governmental agencies of Health Canada, 
CIHR and CCSRI. Moreover, it included a huge number of variables, which offered considerable 
breadth to the study. Past studies have been criticized for excluding people who used e-cigarettes 
and then successfully stopped smoking (McNeill et al., 2014; Science Media Centre, 2016). 
However, this study with the development of e-cigarette sub-groups; persistent, transient and 








C. Recommendations for Future Research 
 
 
Dual-use of e-cigarette and tobacco cigarettes continues to be a major cause of concern. For 
Canadians and the population globally who are trying various types of quit resources to help 
them quit smoking, new policies could be implemented with increasing knowledge about the 
proportion of persistent e-cigarette users, nicotine e-cigarette users, people having high self-
efficacy to quit and their role in smoking cessation. It is noteworthy that many people using e-
cigarettes relapse which is a drawback from a public health standpoint, and above all discourage 
smokers trying to quit. A support in the form of strong and improved research studies is an 
ongoing need. Although the present findings shed light on the relationship between use of e-
cigarettes, socio-demographic, psychological characteristics and smoking cessation, further 
research is needed to clarify the contradictory results found for people with high self-efficacy 
and persistent users. To determine if there is a delayed effect on the levels of self-efficacy among 
persistent e-cigarette users, further longitudinal studies need to be designed in order to provide a 
clear vision to these results. In particular, there is a need to replicate the present study with 
greater number of people over a greater period of time to explore whether dual users who 
continue to smoke for a longer duration may inhibit successful abstinence for specific 
subpopulations, and whether this trend in the relationship between e-cigarette use and cessation 
is observed beyond six months. There is also a need to explore smoker's and EC user's 
perceptions about the use of ECs as a quitting aid. While more people perceive ECs as a 
cessation tool, few people actually quit. Including additional qualitative measures or developing 
qualitative studies to explore whether the nicotine content, advertising, or the type of e-cigarette 
brand and the user's perception has an impact on quitting, and on what grounds the general 
population of smokers switches from cigarettes to e-cigarettes or vice-versa, is recommended for 
future research. 
 
 There is also a need to re-examine and test quitting in the context of motivation theories. 
Social Cognitive theory emphasizes the importance of implementing interventions that increases 
self-efficacy to increase cessation outcomes (Bricker et al., 2010). It is unclear at this point 
precisely what combination of self-efficacy and social norms' factors best predicts quitting. 
Under which circumstances, the smokers are highly motivated to quit smoking and under what 




quitting warrant additional study to better understand why they may quit without using quit 
resources and how they can better be assisted once a quit attempt has been made. The results of 
the preliminary RCT study are underway which may help to address some of these questions and 
limitations.  From a clinical practice and public policy perspective, given the less likelihood of 
quitting among persistent users of e-cigarettes and nicotine e-cigarette users, there is a need to 
develop similar studies to provide evidence for the impact of e-cigarettes in making people 





The current study contributes to the growing body of evidence regarding the dual-use of e-
cigarettes and tobacco cigarettes, and smoking cessation. Consistent with previous research 
findings, it has shown that a majority of dual users who continued to smoke e-cigarettes for 
longer duration were unable to quit. Along with persistent e-cigarette users, people who had ever 
used nicotine-containing e-cigarettes in their life were less likely to quit smoking. Further, it has 
identified that majority of the EC users hold a belief that e-cigarettes help in quitting smoking. 
Consistent with prevailing health behavior change theories, the study findings found the 
psychological construct of self-efficacy to be associated with quitting . Although more research 
is needed, the current study contributes to the dialogue of e-cigarette use among smokers and 
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Appendix A - Surveys 
Appendix A1 - Intake survey 
 
ONLINE INTRO SCRIPT: 
Thank you for your interestin the quitsmoking study being conducted by the Propel Centre for  
Population Health Impact, University of Waterloo. The study purpose is to learn what quit smoking  
programsare most effective for young adult smokers.  
 
STUDY DESCRIPTION 
The study has 3 parts:  
Part 1: Answering questions about yourself and your smoking behaviour to see if you are eligible for the 
study. It should take about 2 minutes. 
 
Next you will be asked to confirm your agreement to participate in the study. If you agree, you will be 
randomly assigned to receive one of two quit smoking programs.  Being randomly assigned means you 
have an equal chance of receiving either one of the quit smoking programs. You will be asked some 
additional questions which should take about 10 minutes. 
 
Part 2: Asks you to use a quit smoking program for the next 6 months to help you in your attempts to 
quit  
 
Part 3: Asks you to complete a 10-minute follow-up survey in 3 months and 6 months from now. We 
will contact you by email with a link to complete the follow-up surveys.  
 
ARE YOU ELIGIBLE? 






Q1 In the last 30 days, how often did you smoke cigarettes? (CHECK ONE) 
_____ Every day (1) 
_____ At least once a week (2) 
_____ At least once in the last 30 days (3) 
_____ Not at all (4) 
[If once/week, once/month or not at all– Thank you for your time but our study requires 
participants to be daily smokers. If you would like more information on quitting smoking please visit 
CCS-Quit Smoking]. 
Q2 [IF smoking status = 1] 
On average , how many cigarettes do you smoke each day 
_____ [enter number] 
_____ Don‘t know 
_____ Refused 




_____ In the past week 
_____ In the past month 
_____ Don‘t know 
_____ Refused 
Q4 Do you intend to quit smoking within the next 30 days? 
_____ Yes 
_____ No (INELIGIBLE - Skip to ‗ineligible‘ script) 
_____ Don‘t Know/Can‘t say (Skip to ‗ineligible‘ script‘) 
[If NOor Don‟t Know/Can‟t Say – Thank you for your time but since this study involves quitting 
smoking, we require individuals who would be willing to quit smoking in the next month. If you 
would like more information on quitting smoking please visit CCS-Quit Smoking]. 
Q5 What is your date of birth? ____ ____ / ____ ____ (mm/yyyy) 
We require this information to determine if participants are between the ages of 19-29, and therefore 
eligible for our study. This study is only suitable for young adult smokers.  
[If not between 19-29 – Thank you for your time but this study is only suitable for young adults 
between the ages of 18-29. If you would like more information on quitting smoking please visit 
CCS-Quit Smoking]. 
Q6 Are you comfortable understanding, reading, and speaking English? 
_____ Yes 
_____ No 
[If NO – Thank you for your time but this study requires that participants are able to fluently 





Q7 Do you currently own and use an Android or iPhone smartphoneor tablet? 
_____ Yes 
_____ No 
[If NO – Thank you for your time but this study requires that participants own an Android or iPhone 
smartphone or tablet for the purposes of being contacted by the research team. If you would like 
more information on quitting smoking please visit CCS-Quit Smoking]. 
 




_____ Don‘t know/can‘t say 
[If YES or Don‟t Know/Can‟t Say – Thank you for your time but this study requires that only one 
individual per household participate in the study. If you would like more information on quitting 
smoking please visit CCS-Quit Smoking] 
Q9 Were you referred to this website by a friend who is already participating in this study? 
_____ Yes 
_____ No 
_____ Don‘t know/can‘t say 
[If YESor Don‟t Know Can‟t Say– Thank you for your time but this study requires individual 
participants who are not acquainted with one another and who have not been referred to the study 
website. If you would like more information on quitting smoking please visit CCS-Quit Smoking] 
ELIGIBILITY – YES 
You are eligible to participate. The information below will help you decide if you want to participate. 
CONSENT PROCESS 
Participation is voluntary. You may stop using the program or withdraw at any time by contacting the research 
team.  If you withdraw, your data will be destroyed.  
 
To thank you for participating you will receive $35; $10now for enrolling in the study,$10for completing the 3 
month follow-up survey,and $15 for completing 6 month follow-up survey.In addition, your name will be 
entered into a draw at the end of the study (Spring 2015), for an iPad 2 Air 64GB. 
 
Responsesare confidential. Only the research team will see your answers.  Data is grouped; no individual is 
identified. Names, emails, and addresses are only used to contactyou for the follow-up survey and to mail you 
$35, and to enter you name into the draw. 
 
Ethics clearance has been given by a University of Waterloo Research Ethics Committee. Contact  
Dr. Maureen Nummelin,at 519-888-4567, Ext. 36005 or Maureen.nummelin@uwaterloo.ca 
if you have concerns. 
 
Questions about the study? 






I understand the information and that by clicking YES, I agree to participate in the research study and 
accept the terms as they are outlined above. 
_____  YES 
_____  NO 
Randomization 
Please provide your email address and a telephone number that you would like us to use to contact you about 
the follow up survey 6 months from now. Please remember that your email and other contact information 
are used by research staff only to contact you for the follow-up surveys. 
Email address:  ___________________________________________ 
Telephone:  [________] [________] [_______________] 
____ REFUSE 
[Script: Thank you but if you are unwilling to provide an email address you will not be eligible to participate 
in the study. We require your email address so that we may contact you for the follow up survey.] 
Please provide your address information so that we can mail you the $10 honorarium for enrolling in the study. 
You will receive $10for completing the follow-up surveyin 3 months and $15 for completing the final survey 6 
months fromnow. In addition, your name will be entered into a draw at the end of the study for an iPad Air 2 
64GB. 
Please remember that your name and other contact information are used by research staff only to send you 
the cheques and enter you name into the draw. 
Full Name:  
Street Address (include Apt. or Unit #) :  ______________________________ 
City/Town:  _____________________________________________ 
Province:  _____________________________________________ 
Postal Code:  ______________________________________________ 
 
Thank you for enrolling in the study. Please click the ‗Save and Continue‘ to finalize your registration for the 
research study and to receive your quit smoking program. [randomize to either 1 or 2] 
 
1. On the Road to Quitting Self-Help Guide – Description 
At the end of the survey we will provide you with a link to download a copy of the On the Road to Quitting 
Self-Help guide for quitting smoking available from Health Canada. We will also email you a copy or you 
may request a hard copy of the guide. 
 
 
In order to participate in the study, you must use the On the Road to Quitting guide over the next six 
months to help you quit smoking.At 3 and 6 months, we will follow up with you to ask about your 
smoking and quitting behaviour and to collect some information about the quit smoking program that you 
received.  
 




At the end of the survey we will provide you with a link to download the Crush the Crave quit smoking 
smartphone app to help you quit smoking. This link will allow you to download the Android or iPhone app 
from either the Google Play or iTunes App Store depending on your phone‘s operating system. 
 
In order to participate in the study, you must use the Crush the Crave smartphone app over the next six 
months to help you quit smoking. At 3 and 6 months, we will follow up with you to ask about your smoking 
and quitting behaviour and to collect some information about the quit smoking program that you received.  
We would now like to continue by asking you a few more questions to collect some additional information 
from you. This should take about 10 minutes. 
Smoking Behaviour Information 
Q10 How soon after you wake up do you smoke your first cigarette? 
____ Within 5 minutes 
____ 6 to 30 minutes 
____ 31 to 60 minutes 
____ More than 60 minutes 
Social Support (NEW QUESTIONS) 
Q11 Does your partner, spouse, or significant other currently smoke?  
_____ Yes  
_____ Yes, but stopping with me   
_____ No, ex-smoker 
_____ No, never smoked  
_____ NA (I do not have a partner/spouse/significant other)  
_____ Don't know 
_____ Refused 
Q12 Including you, how many smokers are there in your household now?  
_____ # 
_____ Don‘t Know 
_____ Refused 
Q13 Of the five closest friends or acquaintances that you spend time with on a regular basis, how 
many of them are smokers?Record # between 0 and 5)   
_____ # 
_____ Don't know 
_____ Refused 
Q14 On a scale from 1 to 5 with 1 being ‘not at all’ and 5 being ‘extremely’, how well supported do 
you expect to be by your partner, friends, and/or colleagues when you quit smoking?  
 1  2  3  4  5 
Not at all          Slightly       Moderately             Very      Extremely 
Q15 On a scale from 1 to 5 with 1 being ‘not at all’ and 5 being ‘extremely’, to what extent do you 
feel you have someone to turn to if you find stopping smoking difficult?  
 1  2  3  4  5 




Q16 On a scale from 1 to 5 with 1 being ‘not at all’ and 5 being ‘extremely’, to what extent do you 
feel that someone is relying on you  to stop smoking this time?  
 
 1  2  3  4  5 




Q17 On a scale from 1 to 5 with 1 being „not at all‟ and 5 being „extremely‟, how confident are you 
in your ability to quit smoking?  
 1  2  3  4  5 
Not at all            Extremely 
Self-Efficacy/Temptation 
Listed below are situations that lead some people to smoke. We would like to know HOW 
TEMPTED you may be to smoke in each situation. Please answer the following questions using the 
following five point scale. 
1 = Not at all tempted 
2 = Not very tempted 
3 = Moderately tempted 
4 = Very tempted 
5 = Extremely tempted 
Q18a When out with 
friends. 
 1  2  3  4  5 
Q18b When I first get up 
in the morning 
 1  2  3  4  5 
Q18c When I am very 
anxious and 
stressed 
 1  2  3  4  5 
Q18d Over coffee while 
talking and 
relaxing 
 1  2  3  4  5 
Q18e When I feel I need 
a lift (e.g. energy 
boost) 
 1  2  3  4  5 




 1  2  3  4  5 
Q18g With my spouse or 
close friend who is 
smoking 
 1  2  3  4  5 
Q18h When I realize I 
haven't smoked for 
a while. 




Q18i When things are 
not going my way 
and I am frustrated 
 1  2  3  4  5 
Q18j When I am talking 
on the phone 
 1  2  3  4  5 
Social norms, Attitudes and Beliefs about Smoking  
Q19 What is your overall opinion of smoking? Is it… ? 
_____ Very positive 
_____ Positive 
_____ Neither positive nor negative 
_____ Negative 
_____ Very negative 
Please indicate whether you agree or disagree with the following statements. There is no right 
or wrong answer - we are most interested in your thoughts.  
Q20 I worry that smoking will damage my health in the future 
_____ Strongly agree 
_____ Agree 
_____ Neither agree nor disagree 
_____ Disagree 
_____ Strongly disagree 
Q21 My friends disapprove of smoking. 
_____ Strongly agree 
_____Agree  
_____ Neither agree nor disagree 
_____ Disagree 
_____Strongly disagree 
Q22 Society disapproves of smoking.  
_____ Strongly agree 
_____ Agree 
_____ Neither agree nor disagree 
_____ Disagree 
_____.Strongly disagree  
Q23 Cigarette smoke is dangerous to non-smokers. 
_____ Strongly agree 
_____ Agree 
_____ Neither agree nor disagree 
_____ Disagree 
_____.Strongly disagree  
Q24 Smoking helps people stay slim.  
_____ Strongly agree 
_____ Agree 
_____ Neither agree nor disagree 
_____ Disagree 





Q25 Smoking helps people feel more comfortable at parties and in other social situations 
_____ Strongly agree 
_____ Agree 
_____ Neither agree nor disagree 
_____ Disagree 
_____Strongly disagree 
Q26 Smoking helps reduce stress 
_____ Strongly agree 
_____ Agree 
_____ Neither agree nor disagree 
_____ Disagree 
_____Strongly disagree 
Q27 Smoking can help people when they are bored. 
_____ Strongly agree_____  
_____ Agree 




Q28 My family disapproves of smoking. 
_____ Strongly agree  
_____Agree 




The questions in this scale ask you about your feelings and thoughts during the last month. In each case, please 
indicate, by circling your response, how often you felt or thought a certain way. 
Q29a In the last month, how often have you felt that you were unable to control the important things in 
your life? 
Never  Almost  Never  Sometimes  Fairly Often  Very 
Often 
 0   1   2    3   4 
Q29b In the last month, how often have you felt confident about your ability to handle your personal 
problems? 
Never  Almost  Never  Sometimes  Fairly Often  Very 
Often 
 0   1   2    3   4 
Q29c In the last month, how often have you felt that things were going your way? 
Never  Almost  Never  Sometimes  Fairly Often  Very 
Often 
 0   1   2    3   4 





Never  Almost  Never  Sometimes  Fairly Often  Very 
Often 
 0   1   2    3   4 
 
Q30 Quit Resources 
We are interested in learning more about what helps people quit. 
Which of the following quit supports have you used in the past or are you currently using? 
(Choose all that apply): 
        Used in the past Using  
           currently 
Telephone quitline/support         
Nicotine replacement therapy products (e.g. gum, patch, inhaler)    
Prescription cessation medications (e.g. Wellbutrin or Champix)     
E-cigarettes           
Health professional advice (e.g. doctor, pharmacist)      
Group cessation programs         
Self-help materials          
Quit smoking contests          
Quit smoking websites          * 
Quit smoking smartphone apps         * 
Social media sites (Facebook/Twitter/Instagram)      * 
Hypnotherapy           
Herbal therapy           
Laser therapy           
Other (Please specify) ___________________________      
 
None of the above 
* Include a text box: ―Please specify‖ 
Demographics 




_____ Other: _______________________________ (please describe) 
Q32 Presently, you are:  
____ Single (never legally married) 
____ Married  
____ Common Law 
____ Separated (but still legally married) 
____ Divorced 
____ Widowed 
____ Prefer not to answer 




Q33 What is the highest level of education you have completed? 
____ Less than high school 
____ High school diploma, certificate, or equivalent 
____ Some post-secondary education without degree, certificate, or diploma 
____ Registered apprenticeship or other trades certificate or diploma 
____ College, CEGEP, or other certificate or diploma 
____ University degree  
____ Refused 
____ Don‘t Know 
Q34 What is your best estimate of your total household income for the last 12 months before taxes 
and deductions? Please include income from all household members and from all sources. Was 
it ... 







____ $120,000 or more 
____ Don‘t Know 
____ Prefer not to answer 
Q35 Do you do any paid work (including self-employed paid work)? 
____ Yes, full-time 
____ Yes, part-time 
____ Yes, but I am on paid leave 
____ Yes, but I am on paid sick or disability leave 
____ Yes, but I am on unpaid leave (leave of absence 
____ No, I am a student 
____ No, I am unemployed 
____ Other(please specify) _____________________ 
____ Don‘t Know 
____ Refused 
Q36 Which population group do you identify with? 




____ South Asian (e.g., East Indian, Pakistani, Sri Lankan, etc.) 
____Black 
____ Fillipino 
____ Latin American 
____ Southeast Asian (e.g., Cambodian, Indonesian, Vietnamese, etc.) 
____ Japanese 
____West Asian (e.g., Afghan, Iranian) 
____ Korean 




____ Don‘t Know 
____ Refused 
Q37 What province or Territory do you live in? 






____ New Brunswick 
____ Nova Scotia 
____ Prince Edward Island 
____ Newfoundland 
____ Yukon 





You are now finished with the survey. We would like to remind you to please use the [On the Road to 
Quittingguide / Crush the Crave smartphone app] over the next six months to help you quit smoking. We will 
be following up with you in 3 months to collect some information from you and see how you‘re doing. 
If you have questions about the study you can contact Laura Holtby, Project Manager, at 519-888-4567, 
extension 35819 or lholtby@uwaterloo.ca 
 
We will be providing you with $10 to thank you for completing this survey. This will be mailed to you  
within 10 business days. Thank you for your participation! 
 













Appendix A2 - 3-Month Follow-up Survey 
 
EMAIL SCRIPT for 3-Month Follow-Up Survey 





We are following up with you about the quit smoking study that you enrolled in 3 months ago. We asked 
you to use the [On the Road to Quitting self-help quit smoking program/Crush the Crave quit smoking 
smartphone app] for 6 months to help you quit smoking.  
 
[When you first enrolled in the study we let you know that we would follow-up with you in 6 months. We 
are contacting at the 3 month mark to ask how you are doing in the quit smoking program].  We would 
like to ask you some questions about your smoking and quitting behaviour, as well as get some feedback 
from you on the quit smoking program you are doing.  The survey should take about 10 minutes to 
complete. To thank you for completing the 3 month survey, we will send you a cheque for $10 now.  As 
a reminder, when you complete the final follow-up survey, you will receive another cheque for $15. You 
will also be entered into a draw for an iPad Air 2 64GB, at the end of the study (spring 2015). 
 
It is important to remember: 
 
 That all your information will be kept private and confidential.  
 This national study is being conducted by the Propel Centre for Population Health Impact and has 
received ethics clearance through a University of Waterloo Research Ethics Committee. 
 If you have any questions about the study and your participation, please contact the Project Manager, 





Smoking Behaviour Information 
1. Do you currently smoke cigarettes or use other tobacco daily, occasionally, or not at all? 
(CHECK ONE) 
_____ Daily 
_____ Occasionally (if less than 7 days per week or less than 1 cigarette per day) 
____ Not at all 
 
2. In the past 3 months,when was the last time you smoked a cigarette or used tobacco, even a 
puff? 
____ ____ / ____ ____ / ____ ____ ____ ____(dd/mm/yyyy) 
 
3. Have you smoked any cigarettes or used other tobacco, even a puff, in the last 30 days? 
_____ Yes 
_____ No (Go to Q7 then go to go to 11) 
_____ Don‘t know 
_____ Refused 
 
4. Have you smoked any cigarettes or used other tobacco, even a puff, in the last 7 days? 
_____ Yes 
_____ No (Go to Q7 then go to go to 11) 




5. On average, how many cigarettes do you smoke per day on the days that you smoke (cigarettes 
per day)? 
_____ # of cigarettes smoked per day(range 1-30+) 
_____ Don‘t know 
_____ Refused 
 
6. In the past 3months, did you stop smoking for at least 24 hours because you were trying to 
quit? 
_____ Yes (go to 7) 




_____ Don‘t know (go to 8) 
_____ Refused (go to 8) 
 
7. In the past 3 months, how many times did you stop using tobacco for 24 hours or longer?(For 
example, if you stopped for 2 days and then started smoking again, and then stopped for a week and 
started smoking again, that counts as 2 quits.) 




8. How soon after you wake up do you smoke your first cigarette? 
____ Within 5 minutes 
____ 6 to 30 minutes 
____ 31 to 60 minutes 
____ More than 60 minutes 
 
 
9. Do you intend to quit smoking within the next 30 days? 
_____ Yes 
_____ No 
_____ Don‘t Know/Can‘t say 
_____ Refused 
 
10. Do you intend to quit smoking within the next 6 months? 
_____ Yes 
_____ No 





11. Since you enrolled in the study 3 months ago, which of the following did you use or are you 
currently using to help you quit smoking? (Choose all that apply): 
 Used in the Past 3 
months 
Currently Using 
a. Telephone quitline/support  
  




gum, patch, inhaler)  
c. Prescription cessation medications (e.g. 





e. Health professional advice (e.g. doctor, 
pharmacist) 
  
f. Group cessation programs 
 
  
g. Self-help materials   
h. Quit smoking contests  
 
  
















m. Herbal therapy  
 
  
N .Laser therapy 
 
  









12. Please rate yourself for the last 7 days,for the following: 
 None Slight Mild Moderate Severe 
a. Angry, irritable, frustrated 0 1 2 3 4 
b. Anxious, nervous 0 1 2 3 4 
c. Depressed mood, sad 0 1 2 3 4 




e. Difficulty concentrating 0 1 2 3 4 
f. Increased appetite, hungry, weight gain 0 1 2 3 4 
g. Insomnia, sleep problems, awakening at night 0 1 2 3 4 
h. Restless  0 1 2 3 4 
i. Impatient 0 1 2 3 4 
j. Constipation 0 1 2 3 4 
k. Dizziness 0 1 2 3 4 
l. Coughing 0 1 2 3 4 
m. Dreaming or nightmares 0 1 2 3 4 
n. Nausea 0 1 2 3 4 




[CTC and Quit Guide Groups] 
 
13. Did you download the [Crush the Crave APP/download or look at the On the Road to Quitting guide]?  
___ Yes (Go to Q15) 
___ No (Go to Q14) 
 
14. Please tell us why you did not download the [CTC APP/download or look at the On the Road to 
Quitting Guide]. 
 
[Open text field] Go to “You have completed all the questions” 
 
15. Over the last three months, how frequently have you [used CTC/looked at or read the On the Road to 
Quitting Guide]?  
____ Never 
____ 1-3 times per month 
____Once a week 






16. Overall, on a scale from 1 to 5, how satisfied would you say you are with the [CTC APP/On the 
Road to Quitting Guide]? 
Not at all satisfied 




[CTC Group only] 
 
17. Which features of the app, if any, did you use (check all that apply)? 
_____ Cigarette tracker 
_____Craving tracker 
_____ Distractions page (Games, Music, Videos) 
_____ Awards page 
_____ My Progress Page 
_____ Health Calculators Page 
_____ My Map feature 
_____ Leader Board feature 
Quit Help Pages: 
_____ My Quit Plan page 
_____ Information Pages (e.g. weight gain, alcohol & tobacco, exercise, etc.) 
_____ Online resources (LTPB, Quit4Life, CCS, Smokers‘ Helpline) 
_____ Call Quitline 
_____ The Crave Community (facebook, twitter) 
_____ Other: Please list:___________________________________________________ 
 
_____None of the above 
 





18. Which features, if any, did you find most helpful in your quitting process (Check all that 
apply)? 
_____ Cigarette tracker 
_____Craving tracker 
_____ Distractions page (Games, Music, Videos) 
_____ Awards page 
_____ My Progress Page 
_____ Health Calculators Page 
_____ My map feature 
_____ Leader board feature 
Quit Help Pages: 
_____ My Quit Plan page 
_____ Information Pages (e.g. weight gain, alcohol & tobacco, exercise, etc.) 
_____ Online resources (LTPB, Quit4Life, CCS, Smokers‘ Helpline) 
_____ Call Quitline 
_____ The Crave Community (facebook, twitter) 
_____ Other: Please list:___________________________________________________ 
 
___None of the above 
 
 
[CTC and Quit Guide Groups] 
 
19. On a scale from 1 to 10 
 How helpful was the [CTC App/On the Road to Quitting Guide]to quit smoking? 
Not 
helpful 









20. Please indicate whether you agree or disagree with the following statements regarding 
Crush the Crave 
20.a I use [Crush the Crave/the Quit Guide] frequently 
___ Strongly agree 
___ Agree 
___ Neither agree nor disagree 
___ Disagree 
___ Strongly disagree 
 
20.b I thought [Crush the Crave/the Quit Guide] was easy to use 
___ Strongly agree 
___ Agree 
___ Neither agree nor disagree 
___ Disagree 
___ Strongly disagree 
20c. I found the [various functions of Crush the Crave well laid out / Quit Guide to 
be well laid out.] 
___ Strongly agree 
___ Agree 
___ Neither agree nor disagree 
___ Disagree 
___ Strongly disagree 
 
 
20d. I felt very confident using [Crush the Crave/Quit Guide] 
___ Strongly agree 
___ Agree 
___ Neither agree nor disagree 
___ Disagree 
___ Strongly disagree 
 
 
[CTC Group only] 
 
21.  So that we can link your CTC APP use information to your survey responses, could you please 
provide us with your CTC username? Please remember that all information you provide is private and 
confidential and will only be seen by project research staff.  
[text field]  
[   ] Don‘t know     






22. Is there anything else you would like to tell us about the Quit Smoking Program you are doing? 
 
[Open text field] 
 
You have now completed all the questions.  
 
As a reminder, we are asking you to use the[CTC APP/ On the Road to Quitting guide] for the next 3 
months. Here is the link to download the [CTC APP/On the Road to Quitting Guide or if would like a 
copy of the Quit Guide mailed to you], please contact the Project Manager, Laura Holtby at 519-888-
4567, extension 35819 or lholtby@uwaterloo.ca. 
 
As a reminder, we will send you a cheque for $10 nowto thank-you for your time completing this survey. 
We will contact you again in 3 months to complete the final follow-up survey and you will receive 
another cheque for $15.You will also be entered into a draw for an iPad Air 2 64GB, at the end of the 
study (spring 2015). 
 
Please confirm your name and address below to make sure you receive your cheque. Don‘t forget to 
include an apartment of unit number, if applicable. 
 
[Insert name and address information collected from baseline survey] 
 
Please remember, only our research team will see your answers and email and contact information are 
used only to send you the cheque, contact you for the follow-up surveys,and enter your name into the 
draw.  
If you have any questions about the study and your participation, please contact Laura Holtby at 519-888-
4567, extension 35819 or lholtby@uwaterloo.ca. 
 




Appendix A3 - 6-Month Follow-up Survey 
 
EMAIL SCRIPT for 6-Month Follow-Up Survey 
 
EMAIL SCRIPT for 6-Month Follow-Up Survey 





We are following up with you about the quit smoking study that you enrolled in 6 months ago. We asked 
you to use the [On the Road to Quitting self-help quit smoking program/Crush the Crave quit smoking 
smartphone app] for 6 months to help you quit smoking.  
 
We would like to ask you some final questions about your smoking and quitting behaviour, as well as get 
some feedback from you on the quit smoking program that you received.  The survey should take about 
15 minutes to complete. To thank you for completing the final6 month survey, we will send you an 
honorarium for $15.  As a reminder, you will also get another entry in the draw to win an iPad Air 2 
64GB. The draw willtake place at the end of the study in the fall of 2015. 
 
It is important to remember: 
 
 That all your information will be kept private and confidential.  
 This national study is being conducted by the Propel Centre for Population Health Impact and has 
received ethics clearance through a University of Waterloo Research Ethics Committee. 
 If you have any questions about the study and your participationplease contact the Project Manager, 
Laura Holtby at 519-888-4567, extension 35819 or lholtby@uwaterloo.ca. 
 
Please click the link below to start the survey 
[URL LINK] 




Q1 Do you currently smoke cigarettes or use other tobacco daily, occasionally, or not at all? 
(CHECK ONE) 
_____ Daily 
_____ Occasionally (if less than 7 days per week or less than 1 cigarette per day) 
_____ Not at all  
 
Q2 In the past 6 months, when was the last time you smoked a cigarette or used tobacco, even 
a puff or a pinch? 
____ ____ / ____ ____ / ____ ____ ____ ____(dd/mm/yyyy) 
 
Q3 Have you smoked any cigarettes or used other tobacco, even a puff, in the last 30 days? 
_____ Yes 
_____ No (Go to Q7 then go to 11) 
_____ Don‘t know 
_____ Refused 
 
Q4 Have you smoked any cigarettes or used other tobacco, even a puff, in the last 7 days? 
_____ Yes 
_____ No(Go to Q7 then go to 11) 
_____ Don‘t know 
_____ Refused 
 
Q5 On average, how many cigarettes do you smoke per day on the days that you smoke? 
_____ # of cigarettes smoked per day (range 1-30+) 
_____ Don‘t know 
_____ Refused 
 
Q6 In the past 6 months, did you stop smoking for at least 24 hours because you were trying to 
quit? 
_____ Yes (go to 7) 
_____ No (go to 8) 
_____ Don‘t know (go to 8) 
_____ Refused (go to 8)  
Q7 In the past 6 months, how many times did you stop using tobacco for 24 hours or longer? 
(For example, if you stopped for 2 days and then started smoking again, and then stopped for a 
week and started smoking again, that counts as 2 quits).  
___ Number of times you quit smoking in the past 6 months (range 1-90) 
___ Don‘t Know 
___ Refused 
 
Q8 How soon after you wake up do you smoke your first cigarette? 
____ Within 5 minutes 
____ 6 to 30 minutes 
____ 31 to 60 minutes 
____ More than 60 minutes 
 
Q9 Do you intend to quit smoking within the next 6 months? 
_____ Yes 
_____ No 






Q10 Do you intend to quit smoking within the next 30 days? 
_____ Yes  
_____ No 
_____ Don‘t Know/Can‘t say  




Social Support  
Q11 Does your partner, spouse, or significant other currently smoke?  
_____ Yes  
_____ Yes, but stopping with me   
_____ No, ex-smoker 
_____ No, never smoked  
_____ NA (I do not have a partner/spouse/significant other)  
_____ Don't know 
_____ Refused 
Q12 Including you, how many smokers are there in your household now?  
_____ # of smokers in your household 
_____ Don‘t Know 
_____ Refused 
Q13 Of the five closest friends or acquaintances that you spend time with on a regular basis, how 
many of them are smokers? 
_____ #(Record # between 0 and 5) 
_____ Don't know 
_____ Refused 
 
Q14 On a scale from 1 to 5 with 1 being ‘not at all’ and 5 being ‘extremely’, how well supported 
were you by your partner, friends, and/or colleagues? 
 1  2  3  4  5 
Not at all          Slightly       Moderately             Very      Extremely 
Q15 On a scale from 1 to 5 with 1 being ‘not at all’ and 5 being ‘extremely’, to what extent did you 
feel you had someone to turn to? 
 1  2  3  4  5 
Not at all              Extremely 
Q16 On a scale from 1 to 5 with 1 being ‘not at all’ and 5 being ‘extremely’, to what extent did you 
feel that someone was relying on you to stop smoking this time?  
 




Not at all            Extremely 
 
Self-Efficacy 
Q17 On a scale from 1 to 5 with 1 being „not at all‟ and 5 being „extremely‟, how confident were 
you in your ability to quit smoking?  
 1  2  3  4  5 
Not at all            Extremely 
Self-Efficacy/Temptation 
Listed below are situations that lead some people to smoke. We would like to know HOW 
TEMPTEDyou are nowto smoke in each situation. Please answer the following questions using the 
following five point scale.1 = Not at all tempted 
2 = Not very tempted 
     3 = Moderately tempted 
4 = Very tempted 
5 = Extremely tempted 
Q18a When out with 
friends. 
 1  2  3  4  5 
Q18b When I first get up 
in the morning 
 1  2  3  4  5 
Q18c When I am very 
anxious and 
stressed 
 1  2  3  4  5 
Q18d Over coffee while 
talking and 
relaxing 
 1  2  3  4  5 
Q18e When I feel I need 
a lift (e.g. energy 
boost) 
 1  2  3  4  5 




 1  2  3  4  5 
Q18g With my spouse or 
close friend who is 
smoking 
 1  2  3  4  5 
Q18h When I realize I 
haven't smoked for 
a while. 
 1  2  3  4  5 
Q18i When things are 
not going my way 
and I am frustrated 




Q18j When I am talking 
on the phone 
 1  2  3  4  5 
Social norms, Attitudes and Beliefs about Smoking  
Q19 What is your overall opinion of smoking? Is it… ? 
_____ Very positive 
_____ Positive 
_____ Neither positive nor negative 
_____ Negative 
_____ Very negative 
Please indicate whether you agree or disagree with the following statements. There is no right 
or wrong answer - we are most interested in your thoughts.  
Q20 I worry that smoking will damage my health in the future 
_____ Strongly agree 
_____ Agree 
_____ Neither agree nor disagree 
_____ Disagree 
_____ Strongly disagree 
Q21 My friends disapprove of smoking. 
_____ Strongly agree 
_____Agree  
_____ Neither agree nor disagree 
_____ Disagree 
_____Strongly disagree 
Q22 Society disapproves of smoking.  
_____ Strongly agree 
_____ Agree 
_____ Neither agree nor disagree 
_____ Disagree 
_____.Strongly disagree  
Q23 Cigarette smoke is dangerous to non-smokers. 
_____ Strongly agree 
_____ Agree 
_____ Neither agree nor disagree 
_____ Disagree 
_____Strongly disagree  
 
 
Q24 Smoking helps people stay slim.  
_____ Strongly agree 
_____ Agree 
_____ Neither agree nor disagree 
_____ Disagree 
_____Strongly disagree  
Q25 Smoking helps people feel more comfortable at parties and in other social situations 





_____ Neither agree nor disagree 
_____ Disagree 
_____Strongly disagree 
Q26 Smoking helps reduce stress 
_____ Strongly agree 
_____ Agree 
_____ Neither agree nor disagree 
_____ Disagree 
_____Strongly disagree 
Q27 Smoking can help people when they are bored. 
_____ Strongly agree_____  
_____ Agree 
_____ Neither agree nor disagree 
_____ Disagree 
_____Strongly disagree 
Q28 My family disapproves of smoking. 
_____ Strongly agree  
_____Agree 




The questions in this scale ask you about your feelings and thoughts during the last month. In each case, please 
indicate, by circling your response, how often you felt or thought a certain way. 
Q29a In the last month, how often have you felt that you were unable to control the important things in 
your life? 
Never  Almost  Never  Sometimes  Fairly Often  Very Often 
 0   1   2    3   4 
Q29b In the last month, how often have you felt confident about your ability to handle your personal 
problems? 
Never  Almost  Never  Sometimes  Fairly Often  Very Often 
 0   1   2    3   4 
Q29c In the last month, how often have you felt that things were going your way? 
Never  Almost  Never  Sometimes  Fairly Often  Very Often 
 0   1   2    3   4 
Q29d In the last month, how often have you felt difficulties were piling up so high that you could not 
overcome them? 
Never  Almost  Never  Sometimes  Fairly Often  Very Often 
 0   1   2    3   4 
Nicotine Withdrawal 




 None Slight Mild Moderate Severe 
a. Angry, irritable, frustrated 0 1 2 3 4 
b. Anxious, nervous 0 1 2 3 4 
c. Depressed mood, sad 0 1 2 3 4 
d. Desire or craving to smoke 0 1 2 3 4 
e. Difficulty concentrating 0 1 2 3 4 
f. Increased appetite, hungry, weight gain 0 1 2 3 4 
g. Insomnia, sleep problems, awakening at 
night 0 1 2 3 4 
h. Restless  0 1 2 3 4 
i. Impatient 0 1 2 3 4 
j. Constipation 0 1 2 3 4 
k. Dizziness 0 1 2 3 4 
l. Coughing 0 1 2 3 4 
m. Dreaming or nightmares 0 1 2 3 4 
n. Nausea 0 1 2 3 4 
o. Sore throat 0 1 2 3 4 
Quit Resources 
Q31. Since you enrolled in the study 6 months ago, which of the following did you use or are you 
currently using to help you quit smoking? (Choose all that apply): 
Resource or Product 
Used in the Past 6 
months 
Currently Using 
p. Telephone quitline/support  
  
b. Nicotine replacement therapy products (e.g. gum, 
patch, inhaler)  
 
  
c. Prescription cessation medications (e.g. Wellbutrin 
or Champix) 
  




e. Group cessation programs 
 
  
f. Self-help materials 
 
  
g. Quit smoking contests  
 
  
















k. Hypnotherapy  
 
  
l. Herbal therapy  
 
  
m .Laser therapy 
 
  




 ________None of the above 
 
 
[If used these items in the last 6 months, items selected above in Q31 will appear as options for Q32] 
 
Use and Cost of Quit Resources or Products 
Q32.Please tell us the name of each quit resource or product, how much of the product you used, the 
number of times you had a program visit, and about how much you spent(and were not reimbursed) 
on each resource or product you used, IN THE LAST 6 MONTHS. 
Resource or Product 
How much did you use 
OR how many times did 
you visit, IN THE LAST 
6 MONTHS 
$ Amount spent,  
IN THE LAST 6 
MONTHS 
(If applicable) 
a. Telephone quitline/support  
 
Please specify program name(s)____________________ 
 
Text field Text field 
b. Nicotine replacement therapy products (e.g. gum, 
patch, inhaler)  
 
Please specify product name(s)____________________ 
 
Text field Text field 
c. Prescription cessation medications (e.g. Wellbutrin or 
Champix) 
Please specify product name(s)____________________ 
 
Text field Text field 
d. Health professional advice (e.g. doctor, pharmacist) 
Please specify type of 
professional(s)_________________________________ 
 




e. Group cessation programs 
Please specify program name(s)____________________ 
 
Text field Text field 
f. Self-help materials 
Please specify material name(s)____________________ 
 
Text field Text field 
i. Quit smoking smartphone apps 
 
Please specify [auto fill from Q30] 
 
Text field Text field 
lk. Hypnotherapy  
 
Please specify program name(s)____________________ 
 
 
Text field Text field 
l. Herbal therapy 
 
Please specify program name(s)____________________ 
 
Text field Text field 
m .Laser therapy 
 
Please specify program name(s)____________________ 
 
Text field Text field 
n. Other (Please specify)  
 
[auto fill from Q30] 
 





Have you ever tried or used an electronic cigarette (e-cigarette, vaporizer)? 
_____Yes [Go to Q34] 
_____ No [Go to Q46] 





Q34 What flavours of electronic cigarette (e-cigarette, vaporizer) have you ever tried or used? 




___Spice (e.g., cinnamon) 
___Candy (e.g., chocolate) 
___Fruit (e.g., strawberry) 
___Alcohol (e.g., piña colada) 













____ Don‘t know 
____Refised 
Q36 Do you have a usual brand of electronic cigarette (e-cigarette, vaporizer) that you use? 
____ Yes (Go to Q37) 
____ No (Go to Q38) 
 
____ Don‘t know 
____ Prefer not to answer 
 




____ Jasper & Jasper 
____ Blu 
____ Dune 
____ Smoke NV 
____ NJOY 
____ Vapor King 
 
Other (please specify):     _______ [open-ended text] 
 
____ Don‘t know 
____Refused 
Q38 In your lifetime, which product did you try first, a “regular” tobacco cigarette or an 
electronic cigarette (e-cigarette, vaporizer)? 
 
____ ―Regular‖ tobacco cigarette 
____ E-cigarette 
 
____ Don‘t know 
____Refused 
 
Q39 In the last 30 days, how often did you electronic cigarettes (e-cigarettes, vaporizer)? 
___ Every day (Go to Q40 ―day‖) 
____At least once a week (Go to Q40 ―weekly‖) 
____At least once in the last 30 days (Go to Q40 ―monthly‖) 





____ Don‘t know 
____ Prefer not to answer 
 
 
Q40 You mentioned that you currently use electronic cigarettes (e-cigarettes, vaporizer) 
[daily/weekly/monthly]. 
On average, how many e-cigarettes / e-cigarette cartridges do you use each day?  
____Number you use each day  
____ Don‘t know  
____Refused 
 
You mentioned that you currently use electronic cigarettes (e-cigarettes, vaporizer) 
[daily/weekly/monthly]. 
On average, how many e-cigarettes / e-cigarette cartridges do you use eachweek?  
____Number you use each week  
____ Don‘t know  
____ Refused 
 
You mentioned that you currently use electronic cigarette (e-cigarette, vaporizer) 
[daily/weekly/monthly]. 
On average, how many e-cigarettes / e-cigarette cartridges do you use each month?  
____Number you use each month (Go to Q42)  
____ Don‘t know (Go to Q42) 
____Refused (Go to Q42) 
Q41 How soon after waking do you usually have your first electronic cigarette (e-cigarette, 
vaporizer)?  
___ Within the first 5 minutes 
___ 6-30 minutes 
___ 31-60 minutes 
___ More than 60 minutes 




Q42 Please tell us why you first tried an electronic cigarette (e-cigarette, vaporizer). I tried an 
e-cigarette because… 
(Select all that apply) 
____ Someone offered me one 
____I thought it would be fun 
____ I thought it might taste good 
____ I was curious what it would be like 
____ I thought it could help me quit smoking 
____ I thought it might be less harmful  to me than a cigarette 
____ I wanted to use it in a place where I couldn‘t smoke 
 





____ Don‘t know 
____Refused 
 
Q43 Please tell us why you currently useelectronic cigarette (e-cigarette, vaporizer). I use e-
cigarettes because…  
(Select all that apply) 
____ They are affordable 
____ They are fun to use 
____ They taste good 
____ Using e-cigarettes might help me to quit smoking 
____ They might be less harmful to me than cigarettes 
____ They might be less harmful to people around me than cigarettes 
____ I can use e-cigarettes in places where smoking isn‘t allowed 
____I don‘t currently use electronic cigarettes 
 
____ Other (please specify):     ___ [open-ended text] 
 































[CTC and Quit Guide Groups] 
 
Intervention Use 
Q46 Did you download the [Crush the Crave APP/download or look at the On the Road to Quitting 
guide]?  
___ Yes (Go to Q15) 
___ No (Go to Q14) 
 
Q47 Please tell us why you did not download the [CTC APP/download or look at the On the Road 
to Quitting Guide]. 
 
[Open text field] Go to ―You have now completed all the questions‖ 
 
Q48 Over the last 6 months, how frequently have you [used CTC/looked at or read the On the Road to 
Quitting Guide]?  
____ Never 
____ 1-3 times per month 
____ Once a week 
____ 2-3 times a week 
____ Daily 
 
Q49 Overall, on a scale from 1 to 5, how satisfied would you say you are with the [CTC 
APP/On the Road to Quitting Guide]? 
 
Not at all satisfied 
1 2 3 4 
Very satisfied 
5 
Q50 Would you use the [CTC APP/Quit guide] again if you needed help quitting smoking? 
 
__ Yes 
__ No  
 






[CTC Group only] 
 
Q51 21. Which features of the app, if any, did you use (check all that apply)? 
_____ Cigarette tracker 
_____ Craving tracker 
_____ Distractions page (Games, Music, Videos) 
_____ Awards page 




_____ Health Calculators Page 
_____ My Map feature 
_____ Leader Board feature 
Quit Help Pages: 
_____ My Quit Plan page 
_____ Information Pages (e.g. weight gain, alcohol & tobacco, exercise, etc.) 
_____ Online resources (LTPB, Quit4Life, CCS, Smokers‘ Helpline) 
_____ Call Quitline 
_____ The Crave Community (facebook, twitter) 
_____ Other: Please list:__________________________________________ 
 
_____None of the above 
[Only items selected in Q36 will appear as options for Q37] 
Q52 Which features, if any, did you find most helpful in your quitting process (Check all 
that apply)?  
_____ Cigarette tracker 
_____Craving tracker 
_____ Distractions page (Games, Music, Videos) 
_____ Awards page 
_____ My Progress Page 
_____ Health Calculators Page 
_____ My map feature 
_____ Leader board feature 
 
Quit Help Pages: 
_____ My Quit Plan page 
_____ Information Pages (e.g. weight gain, alcohol & tobacco, exercise, etc.) 
_____ Online resources (LTPB, Quit4Life, CCS, Smokers‘ Helpline) 
_____ Call Quitline 
_____ The Crave Community (facebook, twitter) 
_____ Other: Please list:__________________________________________ 
 




[CTC and Quit Guide Groups] 
 
Q53 22. On a scale from 1 to 10, how helpful was the [CTC App/On the Road to Quitting 
Guide] to quit smoking? 
 
Not helpful 









Q54 Please indicate whether you agree or disagree with the following statements regarding 
[Crush the Crave APP/On the Road to Quitting guide]. 
a. I use [Crush the Crave/the Quit Guide] frequently 
___ Strongly agree 
___ Agree 
___ Neither agree nor disagree 
___ Disagree 
___ Strongly disagree 
 
 
b. I thought [Crush the Crave/the Quit Guide] was easy to use 
___ Strongly agree 
___ Agree 
___ Neither agree nor disagree 
___ Disagree 
___ Strongly disagree 
c. I found the [various functions of Crush the Crave well laid out / Quit Guide to be well laid 
out.] 
___ Strongly agree 
___ Agree 
___ Neither agree nor disagree 
___ Disagree 
___ Strongly disagree 
 
 
d. I felt very confident using [Crush the Crave/Quit Guide] 
___ Strongly agree 
___ Agree 
___ Neither agree nor disagree 
___ Disagree 




Q55 What aspects of the [Crush the Crave smartphone app/Quit Guide] were most appealing? 
(e.g. design, format, instructions, navigation, terminology, etc.) 
[Open text field] 
 
Q56 Which resources in the [CTC smartphone app/Quit Guide] were most difficult to use? 
[Open text field] 
 
Q57 How could the resources in the [CTC smartphone app/Quit Guide] be improved? 







[CTC Group only] 
 
Q58 So that we can link your CTC APP use information to your survey responses, could you 
please provide us with your CTC username? Please remember that all information you 
provide is private and confidential and will only be seen by project research staff.  
[Open text field]  
___Don‘t know     
___Refused    
 
[CTC and Quit Guide Group] 
Q59 Is there anything else you would like to tell us about the Quit Smoking Program you 
were doing? 
 
[Open text field] 
 
 
You have now completed all the questions.  Thank you very much for your time and help, and for 
participating in our research study!  We will send you an honorarium for $15 in appreciation for your 
completion of the 6 month follow-up survey.  In addition, you will get another entry in the draw to win an 
iPad Air 2 64GB. The draw willtake place at the end of the study in 2015. 
 





Please remember, only our research team will see your answers and email and contact information are 
used only to send you the honorarium and enter you name into the draw. 
 
If you are interested in the study findings, you can contact the Project Manager at the Propel Centre for 
Population Health Impact at the University of Waterloo by phone at 519-888-4567, extension 35819, or 
email at lholtby@uwaterloo.caWe will be happy to share a copy of the final report with you once it 





[If CTC APP Group and ―Yes‖ to download] 
 
Telephone Interview: 
As part of the research study, we are also asking a sample of study participants if they would be 
interested in participating in a 60minute telephone interview to provide some more details about their 
experience using the quit smoking program. Those study participants who take part in the interviews will 
receive up to a$50 honorarium to thank them for their time.  
 
Would you be interested in participating in 30 minute telephone interview to discuss your experience 
using the quit smoking program? 
 
_____ YES 
Great, we will follow up with you shortly to schedule a time to talk with you. Please indicate below the 
telephone number where we can reach you. 
 
PHONE: _________________________________________ 
Okay, thank you so much for your time. We will be in touch with you shortly. 
 
_____ NO  











Appendix B - Descriptive Statistics 
Appendix B1 - Distribution of missing values across baseline and follow-up variables 
 
Baseline variables               na (%) Follow-up variables                na (%) 
Sex 6 (0.7) 
Marital status 3 (0.4) 
Education 4 (0.5) 
Income 83 (9.7) 
Occupation 24 (2.8) 
Ethnicity 23 (2.7) 
Social norms 13 (1.5) 
TTFC 3 (0.3) 
CPD 6 (0.7) 
Self-efficacy 12 (1.4) 
Age/region/quit supports n.a. 
 
Quit (30-day) 14 (1.6) 
Quit (7-day) 16 (1.9) 
E-cigarette use 11 (1.3) 
Ever EC with nicotine use 27 (3.2) 
Quit attempt 12 (1.4) 
Intervention use 18 (2.1) 
Self-efficacy 11 (1.3) 
Social norms 20 (2.4) 
  
 
a- Total number of missing values including 'don't know' or 'refused' responses, n.a.- not applicable 
 
Appendix B2 - Mean CPD (cigarettes per day) at baseline and 6-month follow-up survey based on 
smoker's category 
 
Smoker's category  Baseline Follow-up  p-valuea C.I. 
n, Mean CPD  SD n, Mean CPD  SD  
Cigarette smokers 619, 13.2 8.1 619, 8.1 8.9 <0.01 4.2--6.1 
Persistent EC users  57, 12.7 6.4 57, 8.4 13.6 0.03 0.4--8.2 
Transient EC users  214, 14.3 8.9 214, 7.8 8.9 <0.01 4.8--8.2 
Non-users  341, 12.9 7.6 341, 8.1 8.1 <0.01 3.6--5.9 
a=p-values calculated from paired t-tests. 
n= Total number of smokers at baseline or 6-month follow-up survey who did not quit at 6-month follow-up survey. 
CPD= Cigarettes per day smoked, C.I.= Confidence Interval, SD= Standard deviation 
 
Appendix B3 - Frequency analysis for 30-day and 7-day smoking abstinence 
 
Response 30-day quit 7-day quit 
Quit 218 (26%) 309 (37%) 
Did not quit 619 (74%) 526 (63%) 
 











Appendix C - Situational Analysis 
Appendix C1 - Proportion of e-cigarette and non-users showing high temptations (self-efficacy) for 













When out with friends. 38, 57% 161, 57% 
 
300, 61.5% 5.76 
2.20 
























When I feel I need a lift. (e.g. energy boost) 21, 31% 56, 20% 122, 25% 10.90 
0.03 
When I am very angry about something or 
someone. 
57, 85% 224, 79% 400, 82% 4.90 
0.30 




























When I am talking on the phone. 13, 19% 37, 13% 68, 14% 5.20 
0.26 
Overall high self-efficacy 28, 42.4% 111, 39.4% 194, 40.4% 1.40 
0.85 
aOnly participants who stated 'Highly tempted' to the statements have been mentioned in the table. 
bComparison made for baseline_self-efficacy using χ
2
tests, between participants who were persistent, transient and non-users and who were highly tempted, moderately tempted and not 

























I worry that smoking will damage my health 
in the future.   
63, 93% 259, 91% 443, 91% 0.43 
0.98 


























Smoking helps people stay slim 16, 24% 52, 18% 102, 21% 1.92 
0.75 
Smoking helps people feel more 
comfortable at parties and in other social 
situations. 
33, 49% 160, 57% 290, 59% 3.7 
0.45 


























Overall negative opinion 43, 64% 207, 73% 336, 69% 3.24 
0.52 
a Only participants who stated 'Agreed' to the statements have been mentioned in the table. 
bComparison made using χ
2
tests, between participants who were persistent, transient and non-users and who agreed, disagreed or stated neither for various situations, at 6-month follow-




Appendix C3 - Perceptions of use among persistent and transient e-cigarette users. 
 
Reasons for using ECs Persistent E-cigarette users 
n=68 (n,%) 





Affordable 23 (34%) 59 (27%) 3.7, 0.052 
Fun 9 (13%) 23 (10.5%) 1.2, 0.26 
Tasty 26 (38%) 6 (30.3%) 4, 0.045 
Quit aid 48 (71%) 144 (66%) 5.7, 0.016 
Less harm to me 42 (62%) 106 (49%) 10.7, 0.001 
Less harm to people 36 (53%) 83 (38%) 1.4, 0.23 
In restrictions 17 (25%) 47 (22%) 1.5, 0.21 
aComparison made using χ
2






Appendix D - Most prevalent cessation supports among smoker's categories 
 
 
HPA= Health Care Professional's Advice 











































Appendix E - Logistic Regression Analysis 
Appendix E1 - Multivariable logistic regression for the association between frequency of e-cigarette 
use and 30-day smoking abstinence. 
 
 
Frequency of EC use 
 







Last 30-daysd  16 (13.2)  1.00 1.00 












    
CI = Confidence Interval; OR = Odds Ratio, p-value at 0.05 level of significance. 
aNumber and percent of participants who were abstinent at 30 days at 6-month follow-up in each category.  
bBivariable analysis: series of models that assessed association of all socio-demographics, psychological and usage characteristics individually with 30-day smoking abstinence. 






















Appendix E2 - Multivariable logistic regression for the association between e-cigarette user 






Abstinent na (%) 
Bivariable Multivariable 
 
OR crude 95% C.I. p-value OR adjusted  
allc 
95% C.I. p-value 
(a) Smoker's category 














































































No university/college degreed 

















































































































































































(d) Quit aid and Intervention use 


































    
CI = Confidence Interval; OR = Odds Ratio, p-value at 0.05 level of significance. 
aNumber and percent of participants who were abstinent at 7 days at 6-month follow-up in each category.  
bBivariable analysis: series of models that assessed association of e-cigarette user category, all socio-demographics, psychological and usage characteristics individually with 30-day smoking abstinence.  
cConfounders included in Multivariable analysis: ethnicity, baseline variables (quit aid_current use, self-efficacy, social norms, nicotine dependence) and 6-month variables (quit attempt, intervention user) 
Following regression equation Y =  x1+  x2 + x3 + x4 + x5 + x6 + x7 + x8 + 𝛽0 (constant), where Y= 7-day smoking abstinence and x1= EC use, x2= ethnicity, x3= self-efficacy, x4 = social norms, x5 = nicotine 









} = 𝛽0 + 𝛽1𝑥1+𝛽2𝑥2 + 𝛽3𝑥3 + 𝛽4𝑥4 + 𝛽5𝑥5 + 𝛽6𝑥6 +  𝛽7𝑥7 + 𝛽8𝑥8  
# Variables not included in the final Multivariable model. 





Appendix F - Project Timeline  
 
The following Gantt chart presents the timeline of events that were conducted during the study. 
2016 Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec 
Project development 
and approval 
            
Literature review             
Finalizing Methods 
and approval 
            
2017             
Proposal Defence             
Ethics clearance             
Data Analysis             
Thesis defence and 
Final Submission 
            
 
 
